


Stocks Index - Markets Index
























Bulletin






Investor Alert



















Stocks
Rates
Funds
Bonds
Benchmarks
Real Estate Investment Trusts
Futures
American Depository Receipt Stocks
Exchange Traded Notes
Warrants
Indexes
Exchange Traded Funds
Currencies
Crypto Currencies

Browse Stocks
Stocks A-Z


0-9ABCDEFGHIJKLMNOPQRSTUVWXYZOther

Browse by Location

Argentina
Australia
Austria
Bahamas
Bahrain
Belgium
Bermuda
Botswana
Brazil
British Virgin Islands
Canada
Cayman Islands
Chile
China
Colombia
Curacao
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Gibraltar
Greece
Hong Kong
Hungary
Iceland
India
Indonesia
Ireland
Isle of Man
Israel
Italy
Japan
Jordan
Kazakhstan
Kuwait
Latvia
Lebanon
Liechtenstein
Lithuania
Luxembourg
Malaysia
Malta
Mauritius
Mexico
Monaco
Money Rates
Morocco
Namibia
Netherlands
New Zealand
Norway
Oman
Pakistan
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United States
Venezuela
Western Samoa












Log In




7:14 PM EDT
July 28, 2017


/marketstate/country/us
New York

	After


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
6:50pWall Street isn’t ready for a 1,100-point tumble in the Dow industrials
6:32pThe dark side of cruises
6:32pThe highest paid athletes in the world, in one chart
6:31pO.J. Simpson made over $400,000 while in prison and won’t have to give any of it to the Goldman family
6:31p Trump to Police: 'Don't Be Too Nice'
6:31pHere are 10 co-workers you should avoid like the plague — especially in meetings
6:29pTop 10 most annoying people you may want to unfriend on Facebook 
6:29pThis is one person you should never unfriend on Facebook...
6:29p3 horrible ways typos could alter the course of your life
6:27pPaint your bathroom this color and boost your home’s selling price by $5,400
6:27pAmericans’ new badge of honor: ‘I was blocked by a celebrity!’
6:27p5 weird things I found out about America in my first 24 hours 
6:14pBeyond Tesla: 7 stocks driving the autonomous car revolution
6:14pThese 7 highly taxed companies need Congress to finally act on tax reform
6:11pWatch out: ‘Kids’ are making the most money in this stock market 
6:10p7 real ways for millennials to save money (not by brownbagging and skipping Starbucks)
6:09p‘Game of Thrones’: This computer model predicts who will be killed off — or survive
6:09pThis basic balanced index fund is beating the hedge fund averages
6:08pHere’s one Trump fan who might make you some money
5:58pWhy it might be time to invest in the companies Amazon is destroying
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,830.31

+33.76
+0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,374.68

-7.51
-0.12%





s&p 500

/quotes/zigman/3870025/realtime
2,472.10

-3.32
-0.13%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15


















































 Tekla Life Sciences Investors (HQL) Top Portfolio Holdings 





























Welcome!















Company News
Company Site
Premium
Log In


 



















Membership
Home
Portfolio
Stocks
Bonds
Funds
ETFs
CEF
Markets
Tools
Real Life Finance
Discuss





Investing Ideas


Fund Analyst Picks
Picks by Category
Fund Pick Performance
Picks & Pans E-Newsletter
Fund Spy Column
Fund Spy Book
Bond Squad
Fund Video Reports
FundInvestor Newsletter
ETF Investing
Fund Family Experts



Fund Reports


All Fund Analyst Reports
Fund Stewardship Reports



Fund Ratings


Highest-Rated Value
Highest-Rated Growth
Highest-Rated Large-Cap
Highest-Rated Mid-Cap
Highest-Rated Small-Cap
Foreign Fund Standouts
Star Rating Performance
Rating Methodology



Fund Performance


Top 1-Month Performers
Top YTD Performers
Top 1-Year Performers
Top 3-Year Performers
Top 5-Year Performers
Fund Category Returns
Biggest Daily NAV Changes
Closed-End Funds
Exchange-Traded Funds
Quarterly Market Outlook



Fund Screeners


Basic Screeners
Fund Screener
Long-Term Winners
Solid Small-Growth Funds
Conservative Bond Funds

Premium Screeners
Premium Fund Screener
Index Funds
Hidden Gems
Lower-Risk Foreign Funds


Video Center
 
 

 








Tekla Life Sciences Investors
 HQL


Add to PortfolioGet E-mail AlertsPrint This PageData QuestionQuoteChartCEF AnalysisDistributionPerformanceRatings & RiskPortfolioManagement & FeesOwnershipFilingsSummaryHoldingsPremium Details














                            	Annual Turnover
                            		

Category Avg Turnover
Assets in Top 10 Holdings





31%
44%
54.03%





Stock Holdings(Long)
Stock Holdings(Short)
Bond Holdings(Long)
Bond Holdings(Short)
Other Holdings(Long)
Other Holdings(Short)

 62
—
0
—
37
—






&nbsp


Equity View


Equity Prices





		    	  We value your feedback. Let us know what you think.
		    














 


Site Directory
Site Map
Our Products












 



 



 




Corrections
Help
Advertising Opportunities
Licensing Opportunities
Glossary
RSS
Mobile Portfolio
Affiliate
Careers 
 


International Sites:
        	Australia
Canada
China
France
Germany
Hong Kong
Italy
The Netherlands
Norway
Spain
U.K.
Switzerland

 




Stocks by:
            Name
|
Ticker
|
Star Rating
|
Market Cap
|
Stock Type
|
Sector
|
Industry



Mutual Funds by:
            Star Rating
|
Investment Style
|
Total Assets
|
Category
|
Top Holdings
|
Top Sectors
|
Symbol / Ticker
|
Name



ETFs by:
            Star Rating
|
Category
|
Total Assets
|
Symbol / Ticker
|
Name



Articles by:
            Title
|
Date
|
Author
|
Collection
|
Interest
|
Popularity



Investment Categories by:
            Topic
|
Sector
|
Key Indicators
|
User Interest
|
Market Cap
|
Industry



Premium Stocks by:
            Name
|
Ticker
|
Star Rating
|
Market Cap
|
Stock Type
|
Sector
|
Industry



Premium Mutual Funds by:
            Star Rating
|
Investment Style
|
Total Assets
|
Category
|
Top Holdings
|
Top Sectors
|
Symbol / Ticker
|
Name



Premium ETFs by:
            Star Rating
|
Category
|
Total Assets
|
Symbol / Ticker
|
Name



Popular Articles by:
            Title
|
Date
|
Author
|
Collection
|
Interest
|
Popularity



Popular Investment Categories by:
            Topic
|
Sector
|
Key Indicators
|
User Interest
|
Market Cap
|
Industry




Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.
        © Copyright  Morningstar, Inc. All rights reserved. Please read our Terms of Useand Privacy Policy.Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time. Russell 2000 quote is 10 minutes delayed.
 


 














 








Stocks Index - Markets Index
























Bulletin






Investor Alert



















Stocks
Rates
Funds
Bonds
Benchmarks
Real Estate Investment Trusts
Futures
American Depository Receipt Stocks
Exchange Traded Notes
Warrants
Indexes
Exchange Traded Funds
Currencies
Crypto Currencies

Browse Stocks
Stocks A-Z


0-9ABCDEFGHIJKLMNOPQRSTUVWXYZOther

Browse by Location

Argentina
Australia
Austria
Bahamas
Bahrain
Belgium
Bermuda
Botswana
Brazil
British Virgin Islands
Canada
Cayman Islands
Chile
China
Colombia
Curacao
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Gibraltar
Greece
Hong Kong
Hungary
Iceland
India
Indonesia
Ireland
Isle of Man
Israel
Italy
Japan
Jordan
Kazakhstan
Kuwait
Latvia
Lebanon
Liechtenstein
Lithuania
Luxembourg
Malaysia
Malta
Mauritius
Mexico
Monaco
Money Rates
Morocco
Namibia
Netherlands
New Zealand
Norway
Oman
Pakistan
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United States
Venezuela
Western Samoa












Log In




7:14 PM EDT
July 28, 2017


/marketstate/country/us
New York

	After


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
6:50pWall Street isn’t ready for a 1,100-point tumble in the Dow industrials
6:32pThe dark side of cruises
6:32pThe highest paid athletes in the world, in one chart
6:31pO.J. Simpson made over $400,000 while in prison and won’t have to give any of it to the Goldman family
6:31p Trump to Police: 'Don't Be Too Nice'
6:31pHere are 10 co-workers you should avoid like the plague — especially in meetings
6:29pTop 10 most annoying people you may want to unfriend on Facebook 
6:29pThis is one person you should never unfriend on Facebook...
6:29p3 horrible ways typos could alter the course of your life
6:27pPaint your bathroom this color and boost your home’s selling price by $5,400
6:27pAmericans’ new badge of honor: ‘I was blocked by a celebrity!’
6:27p5 weird things I found out about America in my first 24 hours 
6:14pBeyond Tesla: 7 stocks driving the autonomous car revolution
6:14pThese 7 highly taxed companies need Congress to finally act on tax reform
6:11pWatch out: ‘Kids’ are making the most money in this stock market 
6:10p7 real ways for millennials to save money (not by brownbagging and skipping Starbucks)
6:09p‘Game of Thrones’: This computer model predicts who will be killed off — or survive
6:09pThis basic balanced index fund is beating the hedge fund averages
6:08pHere’s one Trump fan who might make you some money
5:58pWhy it might be time to invest in the companies Amazon is destroying
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,830.31

+33.76
+0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,374.68

-7.51
-0.12%





s&p 500

/quotes/zigman/3870025/realtime
2,472.10

-3.32
-0.13%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15



















































Stocks/Country/United States Index - Markets Index
























Bulletin






Investor Alert



















Stocks
Rates
Funds
Bonds
Benchmarks
Real Estate Investment Trusts
Futures
American Depository Receipt Stocks
Exchange Traded Notes
Warrants
Indexes
Exchange Traded Funds
Currencies
Crypto Currencies

Location: United States



Name
Exchange
Sector




01 Communique Laboratory Inc. (OCQLF)
OOTC
Software


1347 Property Insurance Holdings Inc. (PIH)
XNAS
Non-Life Insurance


1-800-FLOWERS.COM Inc. Cl A (FLWS)
XNAS
Specialty Retail


1pm Industries Inc. (OPMZ)
OOTC
Food Products


1st Capital Bank (CA) (FISB)
OOTC
Banking


1st Constitution Bancorp (FCCY)
XNAS
Banking


1st NRG Corp. (FNRC)
OOTC
Oil Extraction


1st Source Corp. (SRCE)
XNAS
Banking


2050 Motors Inc. (ETFM)
OOTC
Automobiles


21st Century Fox Inc. Cl A (FOXA)
XNAS
Broadcasting


21st Century Fox Inc. Cl B (FOX)
XNAS
Broadcasting


21Vianet Group Inc. ADR (VNET)
XNAS
Internet/Online


22nd Century Group Inc. (XXII)
XASE
Biotechnology


24/7 Kid Doc Inc. (TVMD)
OOTC
Healthcare Provision


2U Inc. (TWOU)
XNAS
Software


2xLeveraged Long E-TRACS Linked to Wells Fargo Business Development Co. Index 052441 (BDCL)
ARCX
Major International Banks


2xLeveraged Long ETRACS Wells Fargo Business Development (LBDC)
ARCX
Major International Banks


3D Eye Solutions Inc. (TDEY)
OOTC
Motion Picture/Sound Recording


3D Pioneer Systems Inc. (DPSM)
OOTC
Software


3D Systems Corp. (DDD)
XNYS
Computers/Consumer Electronics


3DIcon Corp. (TDCP)
OOTC
Software


3Dshopping.com (THDS)
OOTC
Mixed Retailing


3DX Industries Inc. (DDDX)
OOTC
Computers/Consumer Electronics


3i Group PLC ADR (TGOPY)
OOTC
Finance Companies


3M Co. (MMM)
XNYS
Diversified Holding Companies


3Pea International Inc. (TPNL)
XOTC
Accounting


3Power Energy Group Inc. (PSPW)
OOTC
Renewable Energy Generation


3TL Technologies Corp. (TTMZF)
OOTC
Advertising/Marketing/Public Relations


420 Property Management Inc. (FTPM)
OOTC
Real Estate Agents/Brokers


4Cable TV International Inc. (CATV)
OOTC
Diversified Business Services


4Licensing Corp. (FOURQ)
OOTC
Diversified Business Services


500.com Ltd. ADR (WBAI)
XNYS
Gambling Industries


51job Inc. ADR (JOBS)
XNAS
Employment/Training Services


58.com Inc. ADR (WUBA)
XNYS
Consumer Services


5Barz International Inc. (BARZ)
OOTC
Networking


5N Plus Inc. (FPLSF)
OOTC
Commodity Chemicals


6D Global Technologies Inc. (SIXD)
OOTC
Computer Services


808 Renewable Energy Corp. (RNWR)
OOTC
Multiutilities


88 Energy Ltd. ADR (TNGRY)
OOTC
Oil Extraction


888 Holdings PLC (EIHDF)
OOTC
Gambling Industries


8Point3 Energy Partners LP (CAFD)
XNAS
Renewable Energy Generation


8X8 Inc. (EGHT)
XNAS
Wired Telecommunications Services


A Clean Slate Inc. (DRWN)
OOTC
Diversified Business Services


A&W Revenue Royalties Income Fund (AWRRF)
OOTC
Restaurants


A. H. Belo Corp. Series A (AHC)
XNYS
Publishing


A. Schulman Inc. (SHLM)
XNAS
Commodity Chemicals


A. Schulman Inc. 6% Pfd. (SLMNP)
OOTC
Commodity Chemicals


A.D. Makepeace Co. (MAKE)
OOTC
Farming


A.M. Castle & Co. (CAS)
XNYS
Wholesalers


A.O. Smith Corp. (AOS)
XNYS
Building Materials/Products


A.P. Moeller-Maersk A/S ADR (AMKBY)
OOTC
Water Transport/Shipping


A.P. Moeller-Maersk A/S Series A (AMKAF)
OOTC
Water Transport/Shipping


A.P. Moeller-Maersk A/S Series B (AMKBF)
OOTC
Water Transport/Shipping


A.S. Roma S.p.A. (ASRAF)
OOTC
Recreational Services


A-1 Group Inc. (AWON)
OOTC
Tobacco


A10 Networks Inc. (ATEN)
XNYS
Computer Services


a2 Milk Co. Ltd. (ACOPF)
OOTC
Biotechnology


AAC Holdings Inc. (AAC)
XNYS
Healthcare Provision


AAC Technologies Holdings Inc. (AACAF)
OOTC
Industrial Electronics


AAC Technologies Holdings Inc. ADR (AACAY)
OOTC
Industrial Electronics


AAON Inc. (AAON)
XNAS
Building Materials/Products


AAP Inc. (AAPJ)
OOTC
Food Products


AAR Corp. (AIR)
XNYS
Aerospace Products/Parts


Aaron's Inc. (AAN)
XNYS
Consumer Services


AB Science S.A. (ABSCF)
OOTC
Pharmaceuticals


AB Svensk Exportkredit ELEMENTS linked to MLCX Biofuels Index Total Return (FUE)
ARCX
Finance Companies


AB Svensk Exportkredit ELEMENTS linked to MLCX Grain Index Total Return (GRU)
ARCX
Finance Companies


AB&T Financial Corp. (ABTO)
OOTC
Banking


Abacus Mining & Exploration Corp. (ABCFF)
OOTC
General Mining


Abakan Inc. (ABKI)
OOTC
Industrial Products


Abattis Bioceuticals Corp. (ATTBF)
OOTC
Biotechnology


Abaxis Inc. (ABAX)
XNAS
Medical Equipment/Supplies


ABB Ltd. (ABLZF)
OOTC
Industrial Machinery


ABB Ltd. ADR (ABB)
XNYS
Industrial Machinery


Abbott Laboratories (ABT)
XNYS
Pharmaceuticals


AbbVie Inc. (ABBV)
XNYS
Biotechnology


Abby Inc. (ABBY)
OOTC
Oil Extraction


Abcam PLC (ABCZF)
OOTC
Biotechnology


Abcam PLC ADR (ABCZY)
OOTC
Biotechnology


ABCO Energy Inc. (ABCE)
OOTC
Industrial Machinery


Abcourt Mines Inc. (ABMBF)
OOTC
General Mining


Aben Resources Ltd. (ABNAF)
OOTC
General Mining


Abengoa S.A. B (AGOAF)
OOTC
Construction


Abeona Therapeutics Inc. (ABEO)
XNAS
Biotechnology


Abeona Therapeutics Inc. Wt (ABEOW)
XNAS



Abercrombie & Fitch Co. (ANF)
XNYS
Clothing Retail


Aberdeen Asia-Pacific Income Fund Inc. (FAX)
XASE
Closed-End Funds


Aberdeen Asia-Pacific Income Investment Co. Ltd. (ABAKF)
OOTC
Closed-End Funds


Aberdeen Asset Management PLC (ABDNF)
OOTC
Investment Advisors


Aberdeen Asset Management PLC ADR (ABDNY)
OOTC
Investment Advisors


Aberdeen Australia Equity Fund Inc. (IAF)
XASE
Closed-End Funds


Aberdeen Chile Fund Inc. (CH)
XASE
Closed-End Funds


Aberdeen Emerging Markets Smaller Company Opportunities Fund Inc. (ABE)
XASE
Closed-End Funds


Aberdeen Global Income Fund Inc. (FCO)
XASE
Closed-End Funds


Aberdeen Greater China Fund Inc. (GCH)
XNYS
Closed-End Funds


Aberdeen Indonesia Fund Inc. (IF)
XASE
Closed-End Funds


Aberdeen International Inc. (AABVF)
OOTC
General Mining


Aberdeen Israel Fund Inc. (ISL)
XASE
Closed-End Funds


Aberdeen Japan Equity Fund Inc. (JEQ)
XNYS
Closed-End Funds


Aberdeen Latin America Equity Fund Inc. (LAQ)
XASE
Closed-End Funds


Aberdeen Singapore Fund Inc. (SGF)
XNYS
Closed-End Funds


Abertis Infraestructuras S.A. ADR (ABRTY)
OOTC
Transportation Services


Ability Inc. (ABIL)
XNAS
Precision Products


Ability Inc. Wt (ABIWF)
OOTC



Abiomed Inc. (ABMD)
XNAS
Medical Equipment/Supplies


Abitibi Royalties Inc. (ATBYF)
OOTC
General Mining


Able Energy Inc. (ABLE)
OOTC
Gas Utilities


Ablynx N.V. (ABLYF)
OOTC
Biotechnology


ABM Industries Inc. (ABM)
XNYS
Diversified Business Services


Abraxas Petroleum Corp. (AXAS)
XNAS
Oil Extraction


Absecon Bancorp (ASCN)
OOTC
Banking


Absolute Health & Fitness Inc. (AHFI)
OOTC
Recreational Services


Absolute Software Corp. (ALSWF)
OOTC
Software


ABT Holdings Inc. (ABOT)
OOTC
Precious Metals


Abtech Holdings Inc. (ABHD)
OOTC
Industrial Machinery


ABV Consulting Inc. (ABVN)
OOTC
Advertising/Marketing/Public Relations


AC Immune S.A. (ACIU)
XNAS
Biotechnology


Acacia Communications Inc. (ACIA)
XNAS
Networking


Acacia Diversified Holdings Inc. (ACCA)
OOTC
Specialty Retail


Acacia Mining PLC (ABGLF)
OOTC
Gold


Acacia Research Corp. - Acacia Technologies (ACTG)
XNAS
Diversified Business Services


Acadia Healthcare Co. Inc. (ACHC)
XNAS
Healthcare Provision


ACADIA Pharmaceuticals Inc. (ACAD)
XNAS
Biotechnology


Acadia Realty Trust (AKR)
XNYS



Acadian Timber Corp. (ACAZF)
OOTC
Forestry & Wood Products


Acasti Pharma Inc. (ACST)
XNAS
Pharmaceuticals


Accelera Innovations Inc. (ACNV)
OOTC
Healthcare Provision


Accelerate Diagnostics Inc. (AXDX)
XNAS
Biotechnology


Accelerize Inc. (ACLZ)
XOTC
Life Insurance


Acceleron Pharma Inc. (XLRN)
XNAS
Biotechnology


Accenture PLC Cl A (ACN)
XNYS
Diversified Business Services


Access National Corp. (ANCX)
XNAS
Banking


Access Power Inc. (ACCR)
OOTC
Wired Telecommunications Services


Access Worldwide Communications Inc. (AWWC)
OOTC
Advertising/Marketing/Public Relations


Acciona S.A. (ACXIF)
OOTC
Construction


ACCO Brands Corp. (ACCO)
XNYS
Nondurable Household Products


Accor S.A. (ACRFF)
OOTC
Hotels


Accor S.A. ADR (ACCYY)
OOTC
Hotels


Accordia Golf Co. Ltd. (ACGFF)
OOTC
Recreational Services


Accredited Mortgage Loan REIT Trust 9.75% Perp. Cum. Pfd. Series A (AHHAP)
OOTC
Mortgages


Accretive Health Inc. (ACHI)
OOTC
Healthcare Provision


Accuray Inc. (ARAY)
XNAS
Medical Equipment/Supplies


Accuride Corp. (ACW)
XNYS
Auto & Commercial Vehicle Parts


AcelRx Pharmaceuticals Inc. (ACRX)
XNAS
Pharmaceuticals


Acer Inc. GDR Reg S (ACEYY)
OOTC
Computers/Consumer Electronics


Acerus Pharmaceuticals Corp. (TRLPF)
OOTC
Biotechnology


Aceto Corp. (ACET)
XNAS
Specialty Chemicals


Achaogen Inc. (AKAO)
XNAS
Biotechnology


Achillion Pharmaceuticals Inc. (ACHN)
XNAS
Biotechnology


ACI Worldwide Inc. (ACIW)
XNAS
Software



«1234567891011-2021-3031-4041-5051-6061-7071-8081-9091-94»










Log In




7:14 PM EDT
July 28, 2017


/marketstate/country/us
New York

	After


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
6:50pWall Street isn’t ready for a 1,100-point tumble in the Dow industrials
6:32pThe dark side of cruises
6:32pThe highest paid athletes in the world, in one chart
6:31pO.J. Simpson made over $400,000 while in prison and won’t have to give any of it to the Goldman family
6:31p Trump to Police: 'Don't Be Too Nice'
6:31pHere are 10 co-workers you should avoid like the plague — especially in meetings
6:29pTop 10 most annoying people you may want to unfriend on Facebook 
6:29pThis is one person you should never unfriend on Facebook...
6:29p3 horrible ways typos could alter the course of your life
6:27pPaint your bathroom this color and boost your home’s selling price by $5,400
6:27pAmericans’ new badge of honor: ‘I was blocked by a celebrity!’
6:27p5 weird things I found out about America in my first 24 hours 
6:14pBeyond Tesla: 7 stocks driving the autonomous car revolution
6:14pThese 7 highly taxed companies need Congress to finally act on tax reform
6:11pWatch out: ‘Kids’ are making the most money in this stock market 
6:10p7 real ways for millennials to save money (not by brownbagging and skipping Starbucks)
6:09p‘Game of Thrones’: This computer model predicts who will be killed off — or survive
6:09pThis basic balanced index fund is beating the hedge fund averages
6:08pHere’s one Trump fan who might make you some money
5:58pWhy it might be time to invest in the companies Amazon is destroying
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,830.31

+33.76
+0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,374.68

-7.51
-0.12%





s&p 500

/quotes/zigman/3870025/realtime
2,472.10

-3.32
-0.13%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15




















































    HQL Insider Trading - Tekla Life Sciences Investors Transactions - MarketWatch



































Bulletin






Investor Alert





















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Tekla Life Sciences Investors

                  NYSE: HQL
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Tekla Life Sciences Investors



Market closed
 --Quotes are delayed by 20 min
Jul 28, 2017, 4:02 p.m.


HQL

/quotes/zigman/40749403/composite


$
21.65




Change

+0.06
+0.28%

Volume
Volume 58,490
Quotes are delayed by 20 min








/quotes/zigman/40749403/composite
Previous close

$
			21.59
		


$
				21.65
			
Change

+0.06
+0.28%





Day low
Day high
$21.50
$21.82










52 week low
52 week high

            $15.85
        

            $22.23
        



















Sorry, there are no insider transactions for this symbol.

        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    










Transaction Summary
Total insider purchases and sales reported to the SEC
Data not available.



            Officers and Executives
        





Dr. Daniel R. Omstead 
President & Trustee




Ms. Laura F. Woodward 
Secretary, Treasurer & Chief Compliance Officer




Mr. Oleg Michael Pohotsky 
Independent Chairman




Dr. Uwe E. Reinhardt 
Independent Trustee




Mr. Michael W. Bonney 
Independent Trustee




Mr. William S. Reardon 
Independent Trustee




Dr. Rakesh Kumar  Jain 
Independent Trustee




Ms. Lucinda H. Stebbins 
Independent Trustee









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




7:14 PM EDT
July 28, 2017


/marketstate/country/us
New York

	After


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
6:50pWall Street isn’t ready for a 1,100-point tumble in the Dow industrials
6:32pThe dark side of cruises
6:32pThe highest paid athletes in the world, in one chart
6:31pO.J. Simpson made over $400,000 while in prison and won’t have to give any of it to the Goldman family
6:31p Trump to Police: 'Don't Be Too Nice'
6:31pHere are 10 co-workers you should avoid like the plague — especially in meetings
6:29pTop 10 most annoying people you may want to unfriend on Facebook 
6:29pThis is one person you should never unfriend on Facebook...
6:29p3 horrible ways typos could alter the course of your life
6:27pPaint your bathroom this color and boost your home’s selling price by $5,400
6:27pAmericans’ new badge of honor: ‘I was blocked by a celebrity!’
6:27p5 weird things I found out about America in my first 24 hours 
6:14pBeyond Tesla: 7 stocks driving the autonomous car revolution
6:14pThese 7 highly taxed companies need Congress to finally act on tax reform
6:11pWatch out: ‘Kids’ are making the most money in this stock market 
6:10p7 real ways for millennials to save money (not by brownbagging and skipping Starbucks)
6:09p‘Game of Thrones’: This computer model predicts who will be killed off — or survive
6:09pThis basic balanced index fund is beating the hedge fund averages
6:08pHere’s one Trump fan who might make you some money
5:58pWhy it might be time to invest in the companies Amazon is destroying
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,830.31

+33.76
+0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,374.68

-7.51
-0.12%





s&p 500

/quotes/zigman/3870025/realtime
2,472.10

-3.32
-0.13%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15


























































    HQL Analyst Estimates - Tekla Life Sciences Investors Analyst Estimates - MarketWatch



































Bulletin






Investor Alert





















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Tekla Life Sciences Investors

                  NYSE: HQL
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Tekla Life Sciences Investors



Market closed
 --Quotes are delayed by 20 min
Jul 28, 2017, 4:02 p.m.


HQL

/quotes/zigman/40749403/composite


$
21.65




Change

+0.06
+0.28%

Volume
Volume 58,490
Quotes are delayed by 20 min








/quotes/zigman/40749403/composite
Previous close

$
			21.59
		


$
				21.65
			
Change

+0.06
+0.28%





Day low
Day high
$21.50
$21.82










52 week low
52 week high

            $15.85
        

            $22.23
        




























Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




7:14 PM EDT
July 28, 2017


/marketstate/country/us
New York

	After


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
6:50pWall Street isn’t ready for a 1,100-point tumble in the Dow industrials
6:32pThe dark side of cruises
6:32pThe highest paid athletes in the world, in one chart
6:31pO.J. Simpson made over $400,000 while in prison and won’t have to give any of it to the Goldman family
6:31p Trump to Police: 'Don't Be Too Nice'
6:31pHere are 10 co-workers you should avoid like the plague — especially in meetings
6:29pTop 10 most annoying people you may want to unfriend on Facebook 
6:29pThis is one person you should never unfriend on Facebook...
6:29p3 horrible ways typos could alter the course of your life
6:27pPaint your bathroom this color and boost your home’s selling price by $5,400
6:27pAmericans’ new badge of honor: ‘I was blocked by a celebrity!’
6:27p5 weird things I found out about America in my first 24 hours 
6:14pBeyond Tesla: 7 stocks driving the autonomous car revolution
6:14pThese 7 highly taxed companies need Congress to finally act on tax reform
6:11pWatch out: ‘Kids’ are making the most money in this stock market 
6:10p7 real ways for millennials to save money (not by brownbagging and skipping Starbucks)
6:09p‘Game of Thrones’: This computer model predicts who will be killed off — or survive
6:09pThis basic balanced index fund is beating the hedge fund averages
6:08pHere’s one Trump fan who might make you some money
5:58pWhy it might be time to invest in the companies Amazon is destroying
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,830.31

+33.76
+0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,374.68

-7.51
-0.12%





s&p 500

/quotes/zigman/3870025/realtime
2,472.10

-3.32
-0.13%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15




























































Tekla Life Sciences Investors | Company Spotlight Profile











Warning! This site has features that require JavaScript.












watch









        Tekla Life Sciences Investors
        


Sector: 


            Unit Investment Trusts, Face-Amount Certificate Offices, and Closed-End Management Investment Offices
          
Region: 

MA, United States


 
  : 

|
New York Stock Exchange: HQL


  



Listed in: 
Funds & Investment Trusts




          Tekla Life Sciences Investors ("HQL") is a diversified closed-end healthcare fund traded on the New York Stock Exchange under the ticker HQL. HQL primarily invests in the life sciences (including biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies), agriculture and environmental management industries. The Fund's objective is to provide long-term capital appreciation through investments in companies in the life sciences industry believed to have significant potential for above-average long-term growth. Selection will emphasize the smaller, emerging companies with a maximum of 40% of the Fund's assets in restricted securities of both public and private companies. Management believes this provides a unique opportunity not usually available to mutual fund investors.
        


♣ Request Investor Kit

 Contact Investor Relations







 Executives




          Daniel R. Omstead, Ph.D.,
          President and Chief Executive Officer
Daniel R. Omstead, Ph.D., is President and Chief Executive Officer of Tekla Capital Management, LLC. He is also President of H&Q Lifesciences Investors and H&Q Healthcare Investors, two NYSE listed closed-end mutual funds that make venture and public equity investments principally in small, emerging healthcare-related companies. Prior to joining Tekla, Dan was President and CEO of Reprogenesis, Inc. a private development stage biotech company developing therapies in the field of regenerative medicine. In 2000, Reprogenesis was merged with two other biotech companies to form Curis, Inc. Before joining Reprogenesis, Dr. Omstead was Senior Vice President, Research and Development at Cytotherapeutics, Inc a public biotech company that developed CNS therapies. Prior to entering the biotech industry, Dan was employed for fourteen years in the pharmaceutical industry at Ortho Pharmaceutical Corporation and at the R.W. Johnson Pharmaceutical Research Institute, both divisions of Johnson and Johnson and at Merck Sharpe and Dohme Research Laboratories, a division Merck and Company, Inc. While at J&J, Dan participated in the development of Orthoclone OKT3™, Eprex™/Procrit™ and other biological products. While at Merck, he worked on the development of Recombivax™, Mefoxin™, Heartguard™ and other traditional drug products. Dan holds Doctoral and Master’s Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University.
        

          Timothy Gasperoni,
          Senior Vice President, Research
Dr. Gasperoni joined TCM in March of 2015. Previously, he was a Senior Analyst and Founding Member of Sabby Capital, a public and private equity fund focused on biotechnology and medical devices. Dr. Gasperoni was head of Sabby’s research function and led the firm’s venture investment arm. Previously, Dr. Gasperoni was a Partner and Senior Analyst at Crosswind Investments, LLC, a spin-off of Cowen & Co that managed small- and mid-cap growth funds. During Dr. Gasperoni’s tenure at the firm, the funds outperformed their respective benchmarks by over 2500 basis points. Prior to Crosswind, Dr. Gasperoni was the Senior Analyst at Andesite, LLC, a healthcare-dedicated long-short fund. He led the firm’s research function and was responsible for all syndicate transaction. Prior to his career in financial services, Dr. Gasperoni served in consulting, operating, and scientific roles in the biopharmaceutical industry. Dr. Gasperoni holds a B.A. from Swarthmore College, an M.A. from the University of Pennsylvania, a Ph.D. in Neuroscience from UCLA, and an MBA from MIT.

Dr. Gasperoni is responsible for investment research and due diligence in the biotechnology, medical device, and diagnostic areas and serves as a member of the team responsible for making investments on behalf of the Funds.
        

          Christian M. Richard,
          Senior Vice President, Research
Christian Richard joined TCM in March of 2015. Previously, Mr. Richard was a Partner/Head of Research for Merlin Biomed Private Equity/Merlin Nexus for 12 years. Merlin Nexus is a cross-over life sciences fund focused on negotiated transactions in both late-stage private and public companies. Prior to Merlin Nexus, Mr. Richard spent almost five years in the Allergy/Immunology Group at the Schering-Plough Research Institute. He has a B.S. in Cellular and Molecular Biology from Purchase College and both an M.S. in Biochemistry and an M.B.A. in Finance from NYU.

Mr. Richard is responsible for investment research and due diligence in the biotechnology, medical device, and diagnostic areas and serves as a member of the team responsible for making investments on behalf of the Funds.
        

          Jason C. Akus, MD,
          Vice President, Research
Jason Akus is responsible for investment research and due diligence in the Medical Device, Diagnostic, and Biopharmaceutical areas. Jason joined TCM in July of 2001 after graduating from Tufts with an M.D. and M.B.A. Jason graduated from Tufts with a B.S. in Mathematics. During medical school, Jason consulted for a variety of Healthcare IT companies.
        

          Laura Woodward,
          Chief Compliance Officer and Vice President of Fund Administrati
Laura Woodward joined TCM in May 2009 as Chief Compliance Officer and Vice President of Fund Administration. Laura is also Secretary and Treasurer of the Funds. Previously, Laura was a Senior Manager with PricewaterhouseCoopers LLP. Laura is responsible for providing support for and participating in all functions provided by the Adviser to the Funds. Laura is responsible for the administration of the fair valuation process to the extent that the Funds have delegated that duty to the Adviser, certain adviser financial and administrative functions and regulatory compliance matters. Laura is also responsible for developing procedures and policies that are reasonably designed to ensure that the Funds operate in accordance with the Funds’ registration statements. Laura graduated with a B.A. from Lafayette College.
        

          Kolotioloma Silue,
          Manager of Fund Administration
Kolotioloma Silue joined TCM in August 2010. Before joining TCM, Kolotioloma worked as a Business Analyst and Reporting Specialist with JPMorgan Chase & Co. Kolotioloma also worked at Brown Brothers Harriman & Co. as a Mutual Fund Accounting Supervisor from 2001 until 2008. Kolotioloma is responsible for the accuracy and integrity of the Funds’ custody and accounting records and supporting the Chief Compliance Officer in areas such as financial and regulatory reporting and maintaining the system of internal controls. Kolotioloma responsibilities also include assisting the President with projects as assigned. He holds a B.A. degree in Business Economics from the University of Maine.
        





 News & Analysis
















 Related Links


Distributions
News










×
Contact Investor Relations




E-mail:






Your Message:


required field!


If you are seeing (or hearing) this, do not check this box (only check it if you are a robot!):



Tekla Life Sciences Investors
Investor Relations
         2 Liberty Square
         Boston , MA 02109
         United States
Phone:1.617.772.8500

SIC Code:
6726



Submit
Close




×
Request Investor Kit









Select your country:


Afghanistan
Aland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bonaire, St. Eust., Saba
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
Brit. Indian Ocean Terr.
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo (Dem. Rep. of the)
Congo (Rep. of)
Cook Islands
Costa Rica
Croatia
Cuba
Curacao
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Terr.
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard & McDonald Islands
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Ivory Coast
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
La Reunion
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marianas
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Korea
Norway
Oman
Pakistan
Palau
Palestine
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Romania
Russian Federation
Rwanda
Saint Barthelemy
Saint Helena
Saint Kitts and Nevis
Saint Martin
Saint Pierre & Miquelon
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Sint Marten
Slovakia
Slovenia
So Georgia & So Sand Isl
Solomon Islands
Somalia
South Africa
South Korea
Spain
Sri Lanka
St Vincent & Grenadines
St. Lucia
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
U.S. Minor Outlying Isl.
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Uzbekistan
Vanuatu
Vatican City
Venezuela
Vietnam
Virgin Islands
Wallis & Futuna
Western Sahara
Yemen
Zambia
Zimbabwe





E-mail:


required field!



First Name:


required field!



Last Name:


required field!




Street 1:


required field!



Street 2:





City:


required field!



State/Province:


-
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming


required field!



Postal Code:


required field!






 I consent to receiving periodic email communications from Tekla Life Sciences Investors. 
            

 I'd like to receive more information from PrecisionIR.
            







Watch

Watch this company to be notified of upcoming earnings calls and new content with a weekly digest sent to your email.
            
 Watch content
            




Go!
Cancel






Company Spotlight is available free to investors through the financial support of participating companies. In return for receiving this free information, your contact data are made available to the companies whose reports you have ordered, and to other parties as described in our privacy policy, which you can read in its entirety here. In addition, you agree to be contacted by these companies from time to time. You may select at any time to opt out of these communications by using the unsubscribe link in your email(s) or by sending an email to nacustomerservice@precisionir.com.



×
 Enter your email address to watch this company.




E-mail (required):


required field!



First Name:





Last Name:












    Signup 




×
  Enter your email address and notification preferences.




A reminder has been added for this event.



    Add to Calendar
  


Add to Google Calendar


Add to Live Calendar


Add to Yahoo! Calendar


Add to iCalender


Add to Outlook Calendar







Or





Send me a reminder




Weeks

0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52



Days

0
1
2
3
4
5
6



Hours

0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23



Minutes

0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59





before the event.

Please enter a valid email to watch!

First Name

Last Name








    Signup 










Tekla Life Sciences Investors: Private Company Information - Bloomberg









































  





















































































July 28, 2017 7:14 PM ET
Capital Markets

Company Overview of Tekla Life Sciences Investors



Snapshot People




Company Overview
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of b...
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
Detailed Description


2 Liberty Square9th FloorBoston, MA 02109United StatesFounded in 1992



Phone: 617-772-8500

Fax: 617-772-8577

www.teklacap.com/hql.html







Key Executives for Tekla Life Sciences Investors




Dr. Daniel R. Omstead M.S, Ph.D.


      	Principal Executive Officer, President and Trustee 
      


Age: 64
        







Ms. Laura F. Woodward CPA


      	Principal Financial Officer, Chief Compliance Officer, Secretary and Treasurer
      


Age: 49
        







Ms. Betty T. Chang


      	Assistant Treasurer
      


Age: 45
        




Compensation as of Fiscal Year 2017. 

Tekla Life Sciences Investors Key Developments

Tekla Life Sciences Investors Declares Stock Distribution, Payable June 30, 2017
May 19 17
Tekla Life Sciences Investors declared a stock distribution of $0.41 per share. The record date for the stock distribution is May 30, 2017 and the payable date is June 30, 2017.


Tekla Life Sciences Investors, Annual General Meeting, Jun 15, 2017
Apr 18 17
Tekla Life Sciences Investors, Annual General Meeting, Jun 15, 2017, at 09:00 US Eastern Standard Time. Location: Dechert LLP, One International Place 100 Oliver Street, 40th Floor, Boston Massachusetts 02110 United States Agenda: To consider the election of Trustees of the Fund; to consider the ratification or rejection of the selection of Deloitte & Touche LLP as the independent registered public accountants of the Fund for the fiscal year ending September 30, 2017; to consider the take action on a shareholder proposal requesting that the Fund take the steps necessary to reorganize the Board of Trustees into one class with each Trustee subject to election each year, if properly presented at the meeting; and to consider the transaction of such other business as may properly come before the Annual Meeting and any adjournment(s) or postponement(s) thereof.


Tekla Life Sciences Investors Declares Stock Distribution Payable on March 31, 2017
Feb 17 17
On February 17, 2017, Tekla Life Sciences Investors declared a stock distribution of $0.36 per share. The record date for the stock distribution is February 28, 2017 and the payable date is March 31, 2017. The Fund will trade ex-distribution on February 24, 2017.


Similar Private Companies By Industry



Company Name
Region



 @Visory LLC United States 1 Road Partners LLC United States 11T Partners, LLC United States 123Jump.com, Inc. United States 1509225 Ontario, Inc. United States




Recent Private Companies Transactions



TypeDate
Target





Merger/Acquisition

			      April 24, 2017
			    
Akorn, Inc.



Merger/Acquisition

			      March 2, 2017
			    
Neurovance, Inc.



Bankruptcy

			      January 27, 2017
			    
Insightra Medical Inc.





Request Profile Update

















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



Most Searched Private Companies



Company Name
Geographic Region



 Lawyers Committee for Civil Rights Under Law United States NYC2012, Inc. United States The Advertising Council, Inc. United States Bertelsmann AG Europe Rush University United States













Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Tekla Life Sciences Investors, please visit www.teklacap.com/hql.html.  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close



























  HQL Quote - Tekla Life Sciences Investors Fund - Bloomberg Markets                     



     Error: Could not add to watchlist. X   + Watchlist  Tekla Life Sciences Investors   HQL:US   New York        21.65USD   0.06   0.28%     As of 6:40 PM EDT 7/28/2017     Open   21.50    Day Range   21.50 - 21.82    Previous Close   21.59    52Wk Range   15.85 - 22.23    1 Yr Return   20.85%    YTD Return   32.57%                   


                Before it's here, it's on the Bloomberg Terminal.
            

                Learn More
            

         Open   21.50    Day Range   21.50 - 21.82    Volume   58,490    Previous Close   21.59    52Wk Range   15.85 - 22.23    1 Yr Return   21.28%    YTD Return   32.57%    NAV (on 07/27/2017)   21.53000069    Total Assets (m USD) (on 07/27/2017)   459.973    Inception Date   05/08/1992    Premium/Discount   0.28%    Average 52-Week Premium   -3.84%    Fund Managers   DANIEL R OMSTEAD "DAN"    Last Dividend (on 05/30/2017)   0.41    Dividend Indicated Gross Yield   7.55%    Expense Ratio   1.17%    3 Mo Return   9.49%    3 Yr Return   10.87%    5 Yr Return   18.25%                Top Fund Holdings       Name Position Value % of Fund        BIIB:US   Biogen Inc    116.96 k 31.98 m 7.37      GILD:US   Gilead Sciences Inc    443.12 k 30.10 m 6.94      CELG:US   Celgene Corp    241.53 k 30.05 m 6.93      AMGN:US   Amgen Inc    180.08 k 29.55 m 6.81      INCY:US   Incyte Corp    195.82 k 26.18 m 6.04      REGN:US   Regeneron Pharmaceuticals Inc    54.63 k 21.17 m 4.88      VRTX:US   Vertex Pharmaceuticals Inc    191.38 k 20.93 m 4.83      ALXN:US   Alexion Pharmaceuticals Inc    159.70 k 19.36 m 4.47      ILMN:US   Illumina Inc    73.26 k 12.50 m 2.88      BMRN:US   BioMarin Pharmaceutical Inc    142.10 k 12.47 m 2.88           Profile   Tekla Life Sciences Investors is a diversified, closed-end management investment company incorporated in the USA.  The Fund's objective is long-term capital appreciation. The Fund invests mainly in securities of life sciences companies and primarily in securities of public and private companies that are believed to have significant potential for above-average growth.    Address  H & Q Investors2 Liberty Square, 9th FloorBoston, MA 02109USA   Phone  1-617-772-8500   Website   www.teklacap.com              








Tekla Life Sciences Investors Paid Distribution - TheStreet




































































 

 




















Action Alerts PLUS

Access AAPJim Cramer's Best Stocks for 2017Charitable Trust PortfolioMost Recent Trade Alert25 Investing Rules10 Trading Commandments

Real Money

Access RM25 Rules of InvestingJim Cramer's Best Stocks for 201710 CommandmentsStressed Out StocksCramer's Blog

Cramer
Mad Money
ETFs
Futures
Markets
Much More

BanksBiotechRetailTechPersonal FinanceRetirementFinancial Advisor CenterHow to SpendOptionsFixed IncomeVideo










Privacy Policy|Terms of Use© 1996- TheStreet Inc. All rights reserved
















                                DJIA
                            







                                NASDAQ
                            







                                S&P 500
                            






Market Data updated






Sign In




Your Membership(s)








Your Account





Account Preferences


Alerts


Newsletters







Subscribe





Logout



Subscribe

Access insights and guidance from our Wall Street pros. Find the product that's right for you.
Action Alerts PLUS
Action Alerts OPTIONS
Daily Swing Trade
Income Seeker
Quant Ratings
Real Money
Real Money Pro
Stocks Under $10
Top Stocks
Trifecta Stocks
Real Money Pro Portfolio
Chairman's Club
Compare All 
Chatter on the Street













































 








































Tekla Life Sciences Investors Paid Distribution






Business Wire




Jun 30, 2017 2:42 PM EDT













 




























































  On June 30, 2017, Tekla Life Sciences Investors paid a distribution of $0.41 per share. It is currently estimated that this distribution is derived from long-term capital gains. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $169,921,052, of which $134,750,869 represents net unrealized appreciation of portfolio securities.  The following table sets forth the estimated amounts of the current distribution, paid on June 30, 2017, and the cumulative distributions paid this fiscal year-to-date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains, return of capital or other capital source. All amounts are expressed per common share.                                                              Current  Distribution            Percentage Breakdown of  Current Distribution            Total Cumulative  Distributions for the Fiscal  Year to Date  1             Percentage Breakdown of  the Total Cumulative  Distributions for the Fiscal  Year to Date  1      Net Investment Income           $0.0000           0%           $0.0000           0%     Net Realized ST Cap Gains           $0.0000           0%           $0.0000           0%     Net Realized LT Cap Gains           $0.4100           100%           $1.1700           100%     Return of Capital or Other Capital Source           $0.0000           0%           $0.0000           0%     TOTAL (per common share):           $0.4100           100%           $1.1700           100%                                    The table below includes information relating to the Fund's performance based on its NAV for certain periods.                   Average annual return at NAV for the period from May 31, 2012 through May 31, 2017           16.06%     Annualized current distribution rate expressed as percentage of NAV as of May 31, 2017           8.41%     Cumulative total return at NAV for the fiscal year, through May 31, 2017 2           3.85%     Cumulative fiscal year-to-date distribution rate expressed as a percentage of NAV as of May 31, 2017 1           6.00%                  You should not draw any conclusions about the Fund's investment performance from the amount of this distribution or from the terms of the Fund's managed distribution policy.  



 








 










































If you liked this article you might like













Ex-Dividends To Watch: 3 Stocks Going Ex-Dividend Tomorrow: HQH, CATY, L
HQH CATY L are going ex-dividend tomorrow, Friday, February 26, 2016



TheStreet Wire

Feb 25, 2016 10:00 AM EST
























Dividend Watch: 3 Stocks Going Ex-Dividend Monday: DHF, HQL, HQH
DHF HQL HQH are going ex-dividend Monday, Monday, December 28, 2015



TheStreet Wire

Dec 24, 2015 10:00 AM EST
























3 Stocks Going Ex-Dividend Monday: PHF, HQH, SLF
PHF HQH SLF are going ex-dividend Monday, Monday, November 23, 2015



TheStreet Wire

Nov 20, 2015 10:00 AM EST
























Tomorrow's Ex-Dividends To Watch: HQH, OTEX, GXP
HQH OTEX GXP are going ex-dividend tomorrow, Wednesday, August 26, 2015



TheStreet Wire

Aug 25, 2015 10:00 AM EDT








































 











Trending


Tesla Is a Cult Stock, Jim Cramer Says


Can Apple Show Amazon What Earnings Should Look Like?


iPod Nano, Shuffle Are Dead; Here Are 8 Other Discontinued Apple Products


Jim Cramer Nails Starbucks' Big Decline, Warns Again of Downside to $50


Here's Why Snap's Stock Could Be In For Another Big Plunge on Monday











Advertising Partners



 






 






 






 


























 

























 































 


©1996-2017 TheStreet, Inc. All rights reserved.Action Alerts PLUS is a registered trademark of TheStreet, Inc.




Compare Brokers



 







 







 







 







 







 















Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft













    HQL Key Statistics - Tekla Life Sciences Investors Financial Ratios - MarketWatch




































Bulletin






Investor Alert





















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Tekla Life Sciences Investors

                  NYSE: HQL
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Tekla Life Sciences Investors



Market closed
 --Quotes are delayed by 20 min
Jul 28, 2017, 4:02 p.m.


HQL

/quotes/zigman/40749403/composite


$
21.65




Change

+0.06
+0.28%

Volume
Volume 58,490
Quotes are delayed by 20 min








/quotes/zigman/40749403/composite
Previous close

$
			21.59
		


$
				21.65
			
Change

+0.06
+0.28%





Day low
Day high
$21.50
$21.82










52 week low
52 week high

            $15.85
        

            $22.23
        

















      Officers and Executives
    



Name
Age
Officer Since
Title





Dr. Daniel R. Omstead 
64
2001
President & Trustee



Ms. Laura F. Woodward 
48
2009
Secretary, Treasurer & Chief Compliance Officer



Mr. Oleg Michael Pohotsky 
70
2000
Independent Chairman



Dr. Uwe E. Reinhardt 
80
1992
Independent Trustee



Mr. Michael W. Bonney 
58
2011
Independent Trustee





Insider Actions


 – Purchase

 – Sale
1
 – Number of Transactions











{"OrganizationDocuments":[{"Documents":[{"document":[{"reportDateGroup":[{"reportDate":"2011-06-09","tradeTypeGroup":[{"numTransactions":"5","tradeType":"A"}]},{"reportDate":"2011-05-17","tradeTypeGroup":[{"numTransactions":"3","tradeType":"D"},{"numTransactions":"1","tradeType":"A"}]},{"reportDate":"2011-05-16","tradeTypeGroup":[{"numTransactions":"2","tradeType":"D"},{"numTransactions":"8","tradeType":"A"}]},{"reportDate":"2011-05-13","tradeTypeGroup":[{"numTransactions":"1","tradeType":"D"}]},{"reportDate":"2011-05-12","tradeTypeGroup":[{"numTransactions":"1","tradeType":"D"}]},{"reportDate":"2011-05-11","tradeTypeGroup":[{"numTransactions":"1","tradeType":"D"}]},{"reportDate":"2011-05-02","tradeTypeGroup":[{"numTransactions":"1","tradeType":"D"}]},{"reportDate":"2011-03-10","tradeTypeGroup":[{"numTransactions":"5","tradeType":"A"}]},{"reportDate":"2011-02-17","tradeTypeGroup":[{"numTransactions":"4","tradeType":"D"},{"numTransactions":"2","tradeType":"A"}]},{"reportDate":"2011-02-15","tradeTypeGroup":[{"numTransactions":"8","tradeType":"A"},{"numTransactions":"1","tradeType":"D"}]}]}]}]}]}



/news/latest/company/us/hql

      MarketWatch News on HQL
    




 Is this the final stage of the bull market?
4:20 p.m. April 18, 2011
 - Nate Pile, Nate's Notes




 Top performer offers free advice
1:49 a.m. March 4, 2010
 - Peter Brimelow




 Dividend-oriented closed-end funds look attractive
12:09 p.m. April 29, 2008
 - MarketWatch




 Discounts, activist shareholders make for closed-end fund bargains
8:09 a.m. April 29, 2008
 - Chuck Jaffe




 Nate Pile's noteworthy 'rifle-shot' accuracy
7:51 a.m. Jan. 12, 2006
 - Peter Brimelow




 'First-tier' biotech stocks hitting 52-week highs
1:41 p.m. April 26, 2005
 - Nate Pile




 Pharma stocks to continue higher
11:44 a.m. Dec. 29, 2003
 - Nate Pile




 H&Q Life Sciences declares 29 cent stock dividend
1:57 p.m. Feb. 7, 2003
 - Jenny Spitz




 Coke, Checkpoint Systems and more
9:17 p.m. May 27, 2002
 - CBS.MarketWatch.com




 Stocks to watch Tuesday
4:51 p.m. May 25, 2002
 - CBS.MarketWatch.com









/news/nonmarketwatch/company/us/hql

      Other News on HQL
    





Takeover Deals Weaken At Opposite Ends Of The Market

1:08 p.m. July 20, 2017
 - Seeking Alpha





Not Over Til It's Over - U.S. Lawmakers Plan New Health Program Restraints

2:22 p.m. July 19, 2017
 - Seeking Alpha





Delving For The Drivers Of Pharma's Disappearing Deals

3:28 p.m. July 18, 2017
 - Seeking Alpha





2017 On Course For Uptick In Device Approvals

3:53 p.m. July 17, 2017
 - Seeking Alpha





Medtech Venture Funding Total Hits All-Time High

2:43 p.m. July 12, 2017
 - Seeking Alpha





Venture Financing Still Positive But Big Rounds Less Common

10:48 a.m. July 12, 2017
 - Seeking Alpha





The Month In Closed-End Funds: June 2017

3:58 p.m. July 10, 2017
 - Seeking Alpha





Closed End Funds And Capital Preservation

4:25 a.m. July 8, 2017
 - Seeking Alpha





The Chemist's CEF Report - June 2017: Unusual Calm

10:14 a.m. July 5, 2017
 - Seeking Alpha





Health of the healthcare bill?

4:46 a.m. June 26, 2017
 - Seeking Alpha





DC Gives Biopharma Investors A Rosy Second-Half Outlook

2:44 p.m. June 22, 2017
 - Seeking Alpha





Biotechs blaze as Trump draft order on drug prices would ease regulations

7:22 p.m. June 21, 2017
 - Seeking Alpha





Total Worldwide Drug Sales Forecast To Fall As Uncertainty Hits Pharma

3:00 p.m. June 20, 2017
 - Seeking Alpha





WSJ's Grant: In biotech, no news is bad news

2:02 p.m. June 7, 2017
 - Seeking Alpha





2 Bold Biotech Predictions For The 2nd Half Of 2017

9:39 a.m. June 6, 2017
 - Seeking Alpha





Early Liquid Biopsy Data Hint At Grail's Travails

9:27 a.m. June 6, 2017
 - Seeking Alpha





Gilead: A Strong Bet For Income

3:53 p.m. June 4, 2017
 - Seeking Alpha





Trump Budget Plans Double FDA Review Costs

9:01 a.m. May 24, 2017
 - Seeking Alpha





Nanobiotix Turns Up The Heat

12:00 p.m. May 19, 2017
 - Seeking Alpha





Obamacare Repeal Vote The First Move On Congressional Chess Board

3:46 p.m. May 5, 2017
 - Seeking Alpha


Loading more headlines...












At a Glance

Tekla Life Sciences Investors
100 Federal Street
19th floor

Boston, Massachusetts 02110




Phone
1 6177728500


Industry
Closed-End Funds


Sector
Financial Services


Fiscal Year-end
-


View SEC Filings




Revenue
N/A


Net Income
N/A


Employees

        -


Annual Report for HQL











/news/pressrelease/company/us/hql

      Press Releases on HQL
    




 Tekla Healthcare Investors Paid Distribution
2:42 p.m. June 30, 2017
 - BusinessWire - BZX




 Tekla World Healthcare Fund Paid Distribution
2:42 p.m. June 30, 2017
 - BusinessWire - BZX




 Tekla Healthcare Opportunities Fund Paid Distribution
2:42 p.m. June 30, 2017
 - BusinessWire - BZX




 Tekla Life Sciences Investors Paid Distribution
2:42 p.m. June 30, 2017
 - BusinessWire - BZX




 Tekla Life Sciences Investors Announces Results of Annual 
      Shareholders Meeting
4:16 p.m. June 15, 2017
 - BusinessWire - BZX




 Tekla Funds Announce Results of Joint Annual Shareholders Meeting
4:16 p.m. June 15, 2017
 - BusinessWire - BZX




 Tekla Healthcare Opportunities Fund Paid Distribution
11:16 a.m. May 31, 2017
 - BusinessWire - BZX




 Tekla World Healthcare Fund Paid Distribution
11:16 a.m. May 31, 2017
 - BusinessWire - BZX




 CORRECTING and REPLACING Tekla Life Sciences Investors Declares Stock 
      Distribution
12:43 p.m. May 22, 2017
 - BusinessWire - BZX




 Tekla Life Sciences Investors Declares Stock Distribution
11:36 a.m. May 19, 2017
 - BusinessWire - BZX




 Tekla Healthcare Opportunities Fund Paid Distribution
2:32 p.m. April 28, 2017
 - BusinessWire - BZX




 Tekla World Healthcare Fund Paid Distribution
2:32 p.m. April 28, 2017
 - BusinessWire - BZX




 Tekla Healthcare Investors Paid Distribution
1:03 p.m. March 31, 2017
 - BusinessWire - BZX




 Tekla Healthcare Opportunities Fund Paid Distribution
1:02 p.m. March 31, 2017
 - BusinessWire - BZX




 Tekla Life Sciences Investors Paid Distribution
1:02 p.m. March 31, 2017
 - BusinessWire - BZX




 Tekla World Healthcare Fund Paid Distribution
1:02 p.m. March 31, 2017
 - BusinessWire - BZX




 Tekla Life Sciences Investors Announce Renewal of Share Repurchase 
      Program
1:46 p.m. March 23, 2017
 - BusinessWire - BZX




 Tekla World Healthcare Fund Paid Distribution
4:07 p.m. Feb. 28, 2017
 - BusinessWire - BZX




 Tekla Healthcare Opportunities Fund Paid Distribution
4:07 p.m. Feb. 28, 2017
 - BusinessWire - BZX




 Tekla Life Sciences Investors Declares Stock Distribution
2:40 p.m. Feb. 17, 2017
 - BusinessWire - BZX


Loading more headlines...









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




7:14 PM EDT
July 28, 2017


/marketstate/country/us
New York

	After


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
6:50pWall Street isn’t ready for a 1,100-point tumble in the Dow industrials
6:32pThe dark side of cruises
6:32pThe highest paid athletes in the world, in one chart
6:31pO.J. Simpson made over $400,000 while in prison and won’t have to give any of it to the Goldman family
6:31p Trump to Police: 'Don't Be Too Nice'
6:31pHere are 10 co-workers you should avoid like the plague — especially in meetings
6:29pTop 10 most annoying people you may want to unfriend on Facebook 
6:29pThis is one person you should never unfriend on Facebook...
6:29p3 horrible ways typos could alter the course of your life
6:27pPaint your bathroom this color and boost your home’s selling price by $5,400
6:27pAmericans’ new badge of honor: ‘I was blocked by a celebrity!’
6:27p5 weird things I found out about America in my first 24 hours 
6:14pBeyond Tesla: 7 stocks driving the autonomous car revolution
6:14pThese 7 highly taxed companies need Congress to finally act on tax reform
6:11pWatch out: ‘Kids’ are making the most money in this stock market 
6:10p7 real ways for millennials to save money (not by brownbagging and skipping Starbucks)
6:09p‘Game of Thrones’: This computer model predicts who will be killed off — or survive
6:09pThis basic balanced index fund is beating the hedge fund averages
6:08pHere’s one Trump fan who might make you some money
5:58pWhy it might be time to invest in the companies Amazon is destroying
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,830.31

+33.76
+0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,374.68

-7.51
-0.12%





s&p 500

/quotes/zigman/3870025/realtime
2,472.10

-3.32
-0.13%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15
































































Tekla Life Sciences Investors - NYSE:HQL - Stock Quote & News - TheStreet






















 





















Action Alerts PLUS

Access AAPJim Cramer's Best Stocks for 2017Charitable Trust PortfolioMost Recent Trade Alert25 Investing Rules10 Trading Commandments

Real Money

Access RM25 Rules of InvestingJim Cramer's Best Stocks for 201710 CommandmentsStressed Out StocksCramer's Blog

Cramer
Mad Money
ETFs
Futures
Markets
Much More

BanksBiotechRetailTechPersonal FinanceRetirementFinancial Advisor CenterHow to SpendOptionsFixed IncomeVideo










Privacy Policy|Terms of Use© 1996- TheStreet Inc. All rights reserved
















                                DJIA
                            







                                NASDAQ
                            







                                S&P 500
                            






Market Data updated






Sign In




Your Membership(s)








Your Account





Account Preferences


Alerts


Newsletters







Subscribe





Logout



Subscribe

Access insights and guidance from our Wall Street pros. Find the product that's right for you.
Action Alerts PLUS
Action Alerts OPTIONS
Daily Swing Trade
Income Seeker
Quant Ratings
Real Money
Real Money Pro
Stocks Under $10
Top Stocks
Trifecta Stocks
Real Money Pro Portfolio
Chairman's Club
Compare All 
Chatter on the Street













































 






















Tekla Life Sciences Investors (HQL)
Follow




                                    21.67
                                

0.08
0.37




                        NYSE : Financial
                    

Jul 28, 2017 3:59 PM EDT












Prev Close
  21.59


Open
21.50


Day Low/High

                                    21.50 /
                                    21.82


52 Wk Low/High

                                    15.85 /
                                    22.23
                                


Volume
58.49K


Avg Volume 
68.20K











Exchange
NYSE


Shares Outstanding
21.36M


Market Cap
469.34M


P/E Ratio

                                        
                                            N/A
                                        
                                    


Div & Yield

                                        
                                            N.A. (N.A)
                                        
                                    























Trade with Jim Cramer 14 Days FREE 









Latest News









Tekla Healthcare Opportunities Fund Paid Distribution











Tekla World Healthcare Fund Paid Distribution

















Tekla Life Sciences Investors Paid Distribution
On June 30, 2017, Tekla Life Sciences Investors paid a distribution of $0.

Jun 30, 2017 2:42 PM EDT













Tekla Healthcare Investors Paid Distribution
On June 30, 2017, Tekla Healthcare Investors paid a distribution of $0.

Jun 30, 2017 2:42 PM EDT









Tekla Funds Announce Results Of Joint Annual Shareholders Meeting
The Boards of Trustees of Tekla Healthcare Investors (HQH), Tekla Healthcare Opportunities Fund (THQ) and Tekla World Healthcare Fund (THW) are pleased to announce the results from the Funds' joint annual shareholder...

Jun 15, 2017 4:16 PM EDT









Tekla Life Sciences Investors Announces Results Of Annual Shareholders Meeting
The Board of Trustees of Tekla Life Sciences Investors (HQL), is pleased to announce the results from the Fund's annual shareholder meeting held today.

Jun 15, 2017 4:16 PM EDT









Tekla World Healthcare Fund Paid Distribution
On May 31, 2017, Tekla World Healthcare Fund paid a monthly stock distribution of $0.

May 31, 2017 11:16 AM EDT









Tekla Healthcare Opportunities Fund Paid Distribution
On May 31, 2017, Tekla Healthcare Opportunities Fund paid a monthly stock distribution of $0.

May 31, 2017 11:16 AM EDT









Tekla Life Sciences Investors Declares Stock Distribution
On May 19, 2017, Tekla Life Sciences Investors declared a stock distribution of $0.

May 19, 2017 11:36 AM EDT









Tekla World Healthcare Fund Paid Distribution
On April 28, 2017, Tekla World Healthcare Fund paid a monthly stock distribution of $0.

Apr 28, 2017 2:32 PM EDT









Tekla Healthcare Opportunities Fund Paid Distribution
On April 28, 2017, Tekla Healthcare Opportunities Fund paid a monthly stock distribution of $0.

Apr 28, 2017 2:32 PM EDT









Tekla Healthcare Investors Paid Distribution
On March 31, 2017, Tekla Healthcare Investors paid a distribution of $0.

Mar 31, 2017 1:03 PM EDT









Tekla World Healthcare Fund Paid Distribution
On March 31, 2017, Tekla World Healthcare Fund paid a monthly stock distribution of $0.

Mar 31, 2017 1:02 PM EDT









Tekla Life Sciences Investors Paid Distribution
On March 31, 2017, Tekla Life Sciences Investors paid a distribution of $0.

Mar 31, 2017 1:02 PM EDT









Tekla Healthcare Opportunities Fund Paid Distribution
On March 31, 2017, Tekla Healthcare Opportunities Fund paid a monthly stock distribution of $0.

Mar 31, 2017 1:02 PM EDT









Tekla Life Sciences Investors Announce Renewal Of Share Repurchase Program
Tekla Life Sciences Investors (the "Fund") announced today that its Board of Trustees authorized a renewal of its share repurchase program.

Mar 23, 2017 1:46 PM EDT









Tekla World Healthcare Fund Paid Distribution
On February 28, 2017, Tekla World Healthcare Fund paid a monthly stock distribution of $0.

Feb 28, 2017 3:07 PM EST









Tekla Healthcare Opportunities Fund Paid Distribution
On February 28, 2017, Tekla Healthcare Opportunities Fund paid a monthly stock distribution of $0.

Feb 28, 2017 3:07 PM EST









Tekla Life Sciences Investors About To Put More Money In Your Pocket
Looking at the universe of stocks we cover at Dividend Channel, on 2/24/17, Tekla Life Sciences Investors will trade ex-dividend, for its quarterly dividend of $0.36, payable on 3/31/17. As a percentage of HQL's recent stock price of $18.66, this dividend works out to approximately 1.93%, so look for shares of Tekla Life Sciences Investors to trade 1.93% lower — all else being equal — when HQL shares open for trading on 2/24/17.

Feb 22, 2017 11:01 AM EST









Tekla Life Sciences Investors Declares Stock Distribution
On February 17, 2017, Tekla Life Sciences Investors declared a stock distribution of $0.

Feb 17, 2017 1:40 PM EST









Tekla Healthcare Opportunities Fund Paid Distribution
On January 31, 2017, Tekla Healthcare Opportunities Fund paid a monthly stock distribution of $0.

Jan 31, 2017 11:38 AM EST









Tekla World Healthcare Fund Paid Distribution
On January 31, 2017, Tekla World Healthcare Fund paid a monthly stock distribution of $0.

Jan 31, 2017 11:38 AM EST













Tekla Healthcare Opportunities Fund Paid Distribution
On December 30, 2016, Tekla Healthcare Opportunities Fund paid a monthly stock distribution of $0.

Dec 30, 2016 11:47 AM EST













Tekla World Healthcare Fund Paid Distribution
On December 30, 2016, Tekla World Healthcare Fund paid a monthly stock distribution of $0.

Dec 30, 2016 11:47 AM EST













Tekla Healthcare Investors Paid Distribution
On December 30, 2016, Tekla Healthcare Investors paid a distribution of $0.

Dec 30, 2016 11:47 AM EST













Tekla Life Sciences Investors Paid Distribution
On December 30, 2016, Tekla Life Sciences Investors paid a distribution of $0.

Dec 30, 2016 11:47 AM EST













Tekla World Healthcare Fund Paid Distribution
On November 30, 2016, Tekla World Healthcare Fund paid a monthly stock distribution of $0.

Nov 30, 2016 10:53 AM EST













Tekla Healthcare Opportunities Fund Paid Distribution
On November 30, 2016, Tekla Healthcare Opportunities Fund paid a monthly stock distribution of $0.

Nov 30, 2016 10:53 AM EST













Cash Dividend On The Way From Tekla Life Sciences Investors (HQL)
Looking at the universe of stocks we cover at Dividend Channel, on 11/23/16, Tekla Life Sciences Investors will trade ex-dividend, for its quarterly dividend of $0.40, payable on 12/30/16. As a percentage of HQL's recent stock price of $18.50, this dividend works out to approximately 2.16%, so look for shares of Tekla Life Sciences Investors to trade 2.16% lower — all else being equal — when HQL shares open for trading on 11/23/16.

Nov 21, 2016 10:13 AM EST













Tekla Life Sciences Investors Declares Stock Distribution
On November 17, 2016, Tekla Life Sciences Investors declared a stock distribution of $0.

Nov 17, 2016 3:56 PM EST



















Next






Load More








From Our Partners



Takeover Deals Weaken At Opposite Ends Of The Market

SeekingAlpha



Not Over Til It's Over - U.S. Lawmakers Plan New Health Program Restraints

SeekingAlpha



Delving For The Drivers Of Pharma's Disappearing Deals

SeekingAlpha



2017 On Course For Uptick In Device Approvals

SeekingAlpha



Medtech Venture Funding Total Hits All-Time High

SeekingAlpha



Venture Financing Still Positive But Big Rounds Less Common

SeekingAlpha



The Month In Closed-End Funds: June 2017

SeekingAlpha



Closed End Funds And Capital Preservation

SeekingAlpha



Biotechs slip to session low on Alexion probe report

SeekingAlpha



The Chemist's CEF Report - June 2017: Unusual Calm

SeekingAlpha



Health of the healthcare bill?

SeekingAlpha



DC Gives Biopharma Investors A Rosy Second-Half Outlook

SeekingAlpha



Biotechs blaze as Trump draft order on drug prices would ease regulations

SeekingAlpha



Total Worldwide Drug Sales Forecast To Fall As Uncertainty Hits Pharma

SeekingAlpha



WSJ's Grant: In biotech, no news is bad news

SeekingAlpha


































 











Trending


Tesla Is a Cult Stock, Jim Cramer Says


Can Apple Show Amazon What Earnings Should Look Like?


iPod Nano, Shuffle Are Dead; Here Are 8 Other Discontinued Apple Products


Jim Cramer Nails Starbucks' Big Decline, Warns Again of Downside to $50


Here's Why Snap's Stock Could Be In For Another Big Plunge on Monday











Advertising Partners



 






 






 






 


























 

























 







































 


©1996-2017 TheStreet, Inc. All rights reserved.Action Alerts PLUS is a registered trademark of TheStreet, Inc.




Compare Brokers



 







 







 







 







 







 















HQL Annual Income Statement - Tekla Life Sciences Investors Annual Financials



































Bulletin






Investor Alert





















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Tekla Life Sciences Investors

                  NYSE: HQL
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Tekla Life Sciences Investors



Market closed
 --Quotes are delayed by 20 min
Jul 28, 2017, 4:02 p.m.


HQL

/quotes/zigman/40749403/composite


$
21.65




Change

+0.06
+0.28%

Volume
Volume 58,490
Quotes are delayed by 20 min








/quotes/zigman/40749403/composite
Previous close

$
			21.59
		


$
				21.65
			
Change

+0.06
+0.28%





Day low
Day high
$21.50
$21.82










52 week low
52 week high

            $15.85
        

            $22.23
        


















Income Statement


Balance Sheet


Cash Flow Statement


Annual Financials
Quarter Financials




Annual Financials for Tekla Life Sciences Investors


View Ratios


            Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
        







Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




7:14 PM EDT
July 28, 2017


/marketstate/country/us
New York

	After


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
6:50pWall Street isn’t ready for a 1,100-point tumble in the Dow industrials
6:32pThe dark side of cruises
6:32pThe highest paid athletes in the world, in one chart
6:31pO.J. Simpson made over $400,000 while in prison and won’t have to give any of it to the Goldman family
6:31p Trump to Police: 'Don't Be Too Nice'
6:31pHere are 10 co-workers you should avoid like the plague — especially in meetings
6:29pTop 10 most annoying people you may want to unfriend on Facebook 
6:29pThis is one person you should never unfriend on Facebook...
6:29p3 horrible ways typos could alter the course of your life
6:27pPaint your bathroom this color and boost your home’s selling price by $5,400
6:27pAmericans’ new badge of honor: ‘I was blocked by a celebrity!’
6:27p5 weird things I found out about America in my first 24 hours 
6:14pBeyond Tesla: 7 stocks driving the autonomous car revolution
6:14pThese 7 highly taxed companies need Congress to finally act on tax reform
6:11pWatch out: ‘Kids’ are making the most money in this stock market 
6:10p7 real ways for millennials to save money (not by brownbagging and skipping Starbucks)
6:09p‘Game of Thrones’: This computer model predicts who will be killed off — or survive
6:09pThis basic balanced index fund is beating the hedge fund averages
6:08pHere’s one Trump fan who might make you some money
5:58pWhy it might be time to invest in the companies Amazon is destroying
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,830.31

+33.76
+0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,374.68

-7.51
-0.12%





s&p 500

/quotes/zigman/3870025/realtime
2,472.10

-3.32
-0.13%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15



























































    HQL Key Statistics - Tekla Life Sciences Investors Financial Ratios - MarketWatch




































Bulletin






Investor Alert





















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Tekla Life Sciences Investors

                  NYSE: HQL
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Tekla Life Sciences Investors



Market closed
 --Quotes are delayed by 20 min
Jul 28, 2017, 4:02 p.m.


HQL

/quotes/zigman/40749403/composite


$
21.65




Change

+0.06
+0.28%

Volume
Volume 58,490
Quotes are delayed by 20 min








/quotes/zigman/40749403/composite
Previous close

$
			21.59
		


$
				21.65
			
Change

+0.06
+0.28%





Day low
Day high
$21.50
$21.82










52 week low
52 week high

            $15.85
        

            $22.23
        

















      Officers and Executives
    



Name
Age
Officer Since
Title





Dr. Daniel R. Omstead 
64
2001
President & Trustee



Ms. Laura F. Woodward 
48
2009
Secretary, Treasurer & Chief Compliance Officer



Mr. Oleg Michael Pohotsky 
70
2000
Independent Chairman



Dr. Uwe E. Reinhardt 
80
1992
Independent Trustee



Mr. Michael W. Bonney 
58
2011
Independent Trustee





Insider Actions


 – Purchase

 – Sale
1
 – Number of Transactions











{"OrganizationDocuments":[{"Documents":[{"document":[{"reportDateGroup":[{"reportDate":"2011-06-09","tradeTypeGroup":[{"numTransactions":"5","tradeType":"A"}]},{"reportDate":"2011-05-17","tradeTypeGroup":[{"numTransactions":"3","tradeType":"D"},{"numTransactions":"1","tradeType":"A"}]},{"reportDate":"2011-05-16","tradeTypeGroup":[{"numTransactions":"2","tradeType":"D"},{"numTransactions":"8","tradeType":"A"}]},{"reportDate":"2011-05-13","tradeTypeGroup":[{"numTransactions":"1","tradeType":"D"}]},{"reportDate":"2011-05-12","tradeTypeGroup":[{"numTransactions":"1","tradeType":"D"}]},{"reportDate":"2011-05-11","tradeTypeGroup":[{"numTransactions":"1","tradeType":"D"}]},{"reportDate":"2011-05-02","tradeTypeGroup":[{"numTransactions":"1","tradeType":"D"}]},{"reportDate":"2011-03-10","tradeTypeGroup":[{"numTransactions":"5","tradeType":"A"}]},{"reportDate":"2011-02-17","tradeTypeGroup":[{"numTransactions":"4","tradeType":"D"},{"numTransactions":"2","tradeType":"A"}]},{"reportDate":"2011-02-15","tradeTypeGroup":[{"numTransactions":"8","tradeType":"A"},{"numTransactions":"1","tradeType":"D"}]}]}]}]}]}



/news/latest/company/us/hql

      MarketWatch News on HQL
    




 Is this the final stage of the bull market?
4:20 p.m. April 18, 2011
 - Nate Pile, Nate's Notes




 Top performer offers free advice
1:49 a.m. March 4, 2010
 - Peter Brimelow




 Dividend-oriented closed-end funds look attractive
12:09 p.m. April 29, 2008
 - MarketWatch




 Discounts, activist shareholders make for closed-end fund bargains
8:09 a.m. April 29, 2008
 - Chuck Jaffe




 Nate Pile's noteworthy 'rifle-shot' accuracy
7:51 a.m. Jan. 12, 2006
 - Peter Brimelow




 'First-tier' biotech stocks hitting 52-week highs
1:41 p.m. April 26, 2005
 - Nate Pile




 Pharma stocks to continue higher
11:44 a.m. Dec. 29, 2003
 - Nate Pile




 H&Q Life Sciences declares 29 cent stock dividend
1:57 p.m. Feb. 7, 2003
 - Jenny Spitz




 Coke, Checkpoint Systems and more
9:17 p.m. May 27, 2002
 - CBS.MarketWatch.com




 Stocks to watch Tuesday
4:51 p.m. May 25, 2002
 - CBS.MarketWatch.com









/news/nonmarketwatch/company/us/hql

      Other News on HQL
    





Takeover Deals Weaken At Opposite Ends Of The Market

1:08 p.m. July 20, 2017
 - Seeking Alpha





Not Over Til It's Over - U.S. Lawmakers Plan New Health Program Restraints

2:22 p.m. July 19, 2017
 - Seeking Alpha





Delving For The Drivers Of Pharma's Disappearing Deals

3:28 p.m. July 18, 2017
 - Seeking Alpha





2017 On Course For Uptick In Device Approvals

3:53 p.m. July 17, 2017
 - Seeking Alpha





Medtech Venture Funding Total Hits All-Time High

2:43 p.m. July 12, 2017
 - Seeking Alpha





Venture Financing Still Positive But Big Rounds Less Common

10:48 a.m. July 12, 2017
 - Seeking Alpha





The Month In Closed-End Funds: June 2017

3:58 p.m. July 10, 2017
 - Seeking Alpha





Closed End Funds And Capital Preservation

4:25 a.m. July 8, 2017
 - Seeking Alpha





The Chemist's CEF Report - June 2017: Unusual Calm

10:14 a.m. July 5, 2017
 - Seeking Alpha





Health of the healthcare bill?

4:46 a.m. June 26, 2017
 - Seeking Alpha





DC Gives Biopharma Investors A Rosy Second-Half Outlook

2:44 p.m. June 22, 2017
 - Seeking Alpha





Biotechs blaze as Trump draft order on drug prices would ease regulations

7:22 p.m. June 21, 2017
 - Seeking Alpha





Total Worldwide Drug Sales Forecast To Fall As Uncertainty Hits Pharma

3:00 p.m. June 20, 2017
 - Seeking Alpha





WSJ's Grant: In biotech, no news is bad news

2:02 p.m. June 7, 2017
 - Seeking Alpha





2 Bold Biotech Predictions For The 2nd Half Of 2017

9:39 a.m. June 6, 2017
 - Seeking Alpha





Early Liquid Biopsy Data Hint At Grail's Travails

9:27 a.m. June 6, 2017
 - Seeking Alpha





Gilead: A Strong Bet For Income

3:53 p.m. June 4, 2017
 - Seeking Alpha





Trump Budget Plans Double FDA Review Costs

9:01 a.m. May 24, 2017
 - Seeking Alpha





Nanobiotix Turns Up The Heat

12:00 p.m. May 19, 2017
 - Seeking Alpha





Obamacare Repeal Vote The First Move On Congressional Chess Board

3:46 p.m. May 5, 2017
 - Seeking Alpha


Loading more headlines...












At a Glance

Tekla Life Sciences Investors
100 Federal Street
19th floor

Boston, Massachusetts 02110




Phone
1 6177728500


Industry
Closed-End Funds


Sector
Financial Services


Fiscal Year-end
-


View SEC Filings




Revenue
N/A


Net Income
N/A


Employees

        -


Annual Report for HQL











/news/pressrelease/company/us/hql

      Press Releases on HQL
    




 Tekla Healthcare Investors Paid Distribution
2:42 p.m. June 30, 2017
 - BusinessWire - BZX




 Tekla World Healthcare Fund Paid Distribution
2:42 p.m. June 30, 2017
 - BusinessWire - BZX




 Tekla Healthcare Opportunities Fund Paid Distribution
2:42 p.m. June 30, 2017
 - BusinessWire - BZX




 Tekla Life Sciences Investors Paid Distribution
2:42 p.m. June 30, 2017
 - BusinessWire - BZX




 Tekla Life Sciences Investors Announces Results of Annual 
      Shareholders Meeting
4:16 p.m. June 15, 2017
 - BusinessWire - BZX




 Tekla Funds Announce Results of Joint Annual Shareholders Meeting
4:16 p.m. June 15, 2017
 - BusinessWire - BZX




 Tekla Healthcare Opportunities Fund Paid Distribution
11:16 a.m. May 31, 2017
 - BusinessWire - BZX




 Tekla World Healthcare Fund Paid Distribution
11:16 a.m. May 31, 2017
 - BusinessWire - BZX




 CORRECTING and REPLACING Tekla Life Sciences Investors Declares Stock 
      Distribution
12:43 p.m. May 22, 2017
 - BusinessWire - BZX




 Tekla Life Sciences Investors Declares Stock Distribution
11:36 a.m. May 19, 2017
 - BusinessWire - BZX




 Tekla Healthcare Opportunities Fund Paid Distribution
2:32 p.m. April 28, 2017
 - BusinessWire - BZX




 Tekla World Healthcare Fund Paid Distribution
2:32 p.m. April 28, 2017
 - BusinessWire - BZX




 Tekla Healthcare Investors Paid Distribution
1:03 p.m. March 31, 2017
 - BusinessWire - BZX




 Tekla Healthcare Opportunities Fund Paid Distribution
1:02 p.m. March 31, 2017
 - BusinessWire - BZX




 Tekla Life Sciences Investors Paid Distribution
1:02 p.m. March 31, 2017
 - BusinessWire - BZX




 Tekla World Healthcare Fund Paid Distribution
1:02 p.m. March 31, 2017
 - BusinessWire - BZX




 Tekla Life Sciences Investors Announce Renewal of Share Repurchase 
      Program
1:46 p.m. March 23, 2017
 - BusinessWire - BZX




 Tekla World Healthcare Fund Paid Distribution
4:07 p.m. Feb. 28, 2017
 - BusinessWire - BZX




 Tekla Healthcare Opportunities Fund Paid Distribution
4:07 p.m. Feb. 28, 2017
 - BusinessWire - BZX




 Tekla Life Sciences Investors Declares Stock Distribution
2:40 p.m. Feb. 17, 2017
 - BusinessWire - BZX


Loading more headlines...









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




7:14 PM EDT
July 28, 2017


/marketstate/country/us
New York

	After


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
6:50pWall Street isn’t ready for a 1,100-point tumble in the Dow industrials
6:32pThe dark side of cruises
6:32pThe highest paid athletes in the world, in one chart
6:31pO.J. Simpson made over $400,000 while in prison and won’t have to give any of it to the Goldman family
6:31p Trump to Police: 'Don't Be Too Nice'
6:31pHere are 10 co-workers you should avoid like the plague — especially in meetings
6:29pTop 10 most annoying people you may want to unfriend on Facebook 
6:29pThis is one person you should never unfriend on Facebook...
6:29p3 horrible ways typos could alter the course of your life
6:27pPaint your bathroom this color and boost your home’s selling price by $5,400
6:27pAmericans’ new badge of honor: ‘I was blocked by a celebrity!’
6:27p5 weird things I found out about America in my first 24 hours 
6:14pBeyond Tesla: 7 stocks driving the autonomous car revolution
6:14pThese 7 highly taxed companies need Congress to finally act on tax reform
6:11pWatch out: ‘Kids’ are making the most money in this stock market 
6:10p7 real ways for millennials to save money (not by brownbagging and skipping Starbucks)
6:09p‘Game of Thrones’: This computer model predicts who will be killed off — or survive
6:09pThis basic balanced index fund is beating the hedge fund averages
6:08pHere’s one Trump fan who might make you some money
5:58pWhy it might be time to invest in the companies Amazon is destroying
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,830.31

+33.76
+0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,374.68

-7.51
-0.12%





s&p 500

/quotes/zigman/3870025/realtime
2,472.10

-3.32
-0.13%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15



























































    HQL News - Tekla Life Sciences Investors Company News & Press Releases - MarketWatch




































Bulletin






Investor Alert





















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Tekla Life Sciences Investors

                  NYSE: HQL
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Tekla Life Sciences Investors



Market closed
 --Quotes are delayed by 20 min
Jul 28, 2017, 4:02 p.m.


HQL

/quotes/zigman/40749403/composite


$
21.65




Change

+0.06
+0.28%

Volume
Volume 58,490
Quotes are delayed by 20 min








/quotes/zigman/40749403/composite
Previous close

$
			21.59
		


$
				21.65
			
Change

+0.06
+0.28%





Day low
Day high
$21.50
$21.82










52 week low
52 week high

            $15.85
        

            $22.23
        

















/news/latest/company/us/hql

      MarketWatch News on HQL
    




 Is this the final stage of the bull market?
4:20 p.m. April 18, 2011
 - Nate Pile, Nate's Notes




 Top performer offers free advice
1:49 a.m. March 4, 2010
 - Peter Brimelow




 Dividend-oriented closed-end funds look attractive
12:09 p.m. April 29, 2008
 - MarketWatch




 Discounts, activist shareholders make for closed-end fund bargains
8:09 a.m. April 29, 2008
 - Chuck Jaffe




 Nate Pile's noteworthy 'rifle-shot' accuracy
7:51 a.m. Jan. 12, 2006
 - Peter Brimelow




 'First-tier' biotech stocks hitting 52-week highs
1:41 p.m. April 26, 2005
 - Nate Pile




 Pharma stocks to continue higher
11:44 a.m. Dec. 29, 2003
 - Nate Pile




 H&Q Life Sciences declares 29 cent stock dividend
1:57 p.m. Feb. 7, 2003
 - Jenny Spitz




 Coke, Checkpoint Systems and more
9:17 p.m. May 27, 2002
 - CBS.MarketWatch.com




 Stocks to watch Tuesday
4:51 p.m. May 25, 2002
 - CBS.MarketWatch.com











/news/nonmarketwatch/company/us/hql

      Other News on HQL
    





Takeover Deals Weaken At Opposite Ends Of The Market

1:08 p.m. July 20, 2017
 - Seeking Alpha





Not Over Til It's Over - U.S. Lawmakers Plan New Health Program Restraints

2:22 p.m. July 19, 2017
 - Seeking Alpha





Delving For The Drivers Of Pharma's Disappearing Deals

3:28 p.m. July 18, 2017
 - Seeking Alpha





2017 On Course For Uptick In Device Approvals

3:53 p.m. July 17, 2017
 - Seeking Alpha





Medtech Venture Funding Total Hits All-Time High

2:43 p.m. July 12, 2017
 - Seeking Alpha





Venture Financing Still Positive But Big Rounds Less Common

10:48 a.m. July 12, 2017
 - Seeking Alpha





The Month In Closed-End Funds: June 2017

3:58 p.m. July 10, 2017
 - Seeking Alpha





Closed End Funds And Capital Preservation

4:25 a.m. July 8, 2017
 - Seeking Alpha





The Chemist's CEF Report - June 2017: Unusual Calm

10:14 a.m. July 5, 2017
 - Seeking Alpha





Health of the healthcare bill?

4:46 a.m. June 26, 2017
 - Seeking Alpha





DC Gives Biopharma Investors A Rosy Second-Half Outlook

2:44 p.m. June 22, 2017
 - Seeking Alpha





Biotechs blaze as Trump draft order on drug prices would ease regulations

7:22 p.m. June 21, 2017
 - Seeking Alpha





Total Worldwide Drug Sales Forecast To Fall As Uncertainty Hits Pharma

3:00 p.m. June 20, 2017
 - Seeking Alpha





WSJ's Grant: In biotech, no news is bad news

2:02 p.m. June 7, 2017
 - Seeking Alpha





2 Bold Biotech Predictions For The 2nd Half Of 2017

9:39 a.m. June 6, 2017
 - Seeking Alpha





Early Liquid Biopsy Data Hint At Grail's Travails

9:27 a.m. June 6, 2017
 - Seeking Alpha





Gilead: A Strong Bet For Income

3:53 p.m. June 4, 2017
 - Seeking Alpha





Trump Budget Plans Double FDA Review Costs

9:01 a.m. May 24, 2017
 - Seeking Alpha





Nanobiotix Turns Up The Heat

12:00 p.m. May 19, 2017
 - Seeking Alpha





Obamacare Repeal Vote The First Move On Congressional Chess Board

3:46 p.m. May 5, 2017
 - Seeking Alpha


Loading more headlines...







/news/pressrelease/company/us/hql

      Press Releases on HQL
    




 Tekla Healthcare Investors Paid Distribution
2:42 p.m. June 30, 2017
 - BusinessWire - BZX




 Tekla World Healthcare Fund Paid Distribution
2:42 p.m. June 30, 2017
 - BusinessWire - BZX




 Tekla Healthcare Opportunities Fund Paid Distribution
2:42 p.m. June 30, 2017
 - BusinessWire - BZX




 Tekla Life Sciences Investors Paid Distribution
2:42 p.m. June 30, 2017
 - BusinessWire - BZX




 Tekla Life Sciences Investors Announces Results of Annual 
      Shareholders Meeting
4:16 p.m. June 15, 2017
 - BusinessWire - BZX




 Tekla Funds Announce Results of Joint Annual Shareholders Meeting
4:16 p.m. June 15, 2017
 - BusinessWire - BZX




 Tekla Healthcare Opportunities Fund Paid Distribution
11:16 a.m. May 31, 2017
 - BusinessWire - BZX




 Tekla World Healthcare Fund Paid Distribution
11:16 a.m. May 31, 2017
 - BusinessWire - BZX




 CORRECTING and REPLACING Tekla Life Sciences Investors Declares Stock 
      Distribution
12:43 p.m. May 22, 2017
 - BusinessWire - BZX




 Tekla Life Sciences Investors Declares Stock Distribution
11:36 a.m. May 19, 2017
 - BusinessWire - BZX




 Tekla Healthcare Opportunities Fund Paid Distribution
2:32 p.m. April 28, 2017
 - BusinessWire - BZX




 Tekla World Healthcare Fund Paid Distribution
2:32 p.m. April 28, 2017
 - BusinessWire - BZX




 Tekla Healthcare Investors Paid Distribution
1:03 p.m. March 31, 2017
 - BusinessWire - BZX




 Tekla Healthcare Opportunities Fund Paid Distribution
1:02 p.m. March 31, 2017
 - BusinessWire - BZX




 Tekla Life Sciences Investors Paid Distribution
1:02 p.m. March 31, 2017
 - BusinessWire - BZX




 Tekla World Healthcare Fund Paid Distribution
1:02 p.m. March 31, 2017
 - BusinessWire - BZX




 Tekla Life Sciences Investors Announce Renewal of Share Repurchase 
      Program
1:46 p.m. March 23, 2017
 - BusinessWire - BZX




 Tekla World Healthcare Fund Paid Distribution
4:07 p.m. Feb. 28, 2017
 - BusinessWire - BZX




 Tekla Healthcare Opportunities Fund Paid Distribution
4:07 p.m. Feb. 28, 2017
 - BusinessWire - BZX




 Tekla Life Sciences Investors Declares Stock Distribution
2:40 p.m. Feb. 17, 2017
 - BusinessWire - BZX


Loading more headlines...

























Log In




7:14 PM EDT
July 28, 2017


/marketstate/country/us
New York

	After


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
6:50pWall Street isn’t ready for a 1,100-point tumble in the Dow industrials
6:32pThe dark side of cruises
6:32pThe highest paid athletes in the world, in one chart
6:31pO.J. Simpson made over $400,000 while in prison and won’t have to give any of it to the Goldman family
6:31p Trump to Police: 'Don't Be Too Nice'
6:31pHere are 10 co-workers you should avoid like the plague — especially in meetings
6:29pTop 10 most annoying people you may want to unfriend on Facebook 
6:29pThis is one person you should never unfriend on Facebook...
6:29p3 horrible ways typos could alter the course of your life
6:27pPaint your bathroom this color and boost your home’s selling price by $5,400
6:27pAmericans’ new badge of honor: ‘I was blocked by a celebrity!’
6:27p5 weird things I found out about America in my first 24 hours 
6:14pBeyond Tesla: 7 stocks driving the autonomous car revolution
6:14pThese 7 highly taxed companies need Congress to finally act on tax reform
6:11pWatch out: ‘Kids’ are making the most money in this stock market 
6:10p7 real ways for millennials to save money (not by brownbagging and skipping Starbucks)
6:09p‘Game of Thrones’: This computer model predicts who will be killed off — or survive
6:09pThis basic balanced index fund is beating the hedge fund averages
6:08pHere’s one Trump fan who might make you some money
5:58pWhy it might be time to invest in the companies Amazon is destroying
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,830.31

+33.76
+0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,374.68

-7.51
-0.12%





s&p 500

/quotes/zigman/3870025/realtime
2,472.10

-3.32
-0.13%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15


























































    HQL SEC Filings - Tekla Life Sciences Investors SEC Filings - MarketWatch




































Bulletin






Investor Alert





















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Tekla Life Sciences Investors

                  NYSE: HQL
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Tekla Life Sciences Investors



Market closed
 --Quotes are delayed by 20 min
Jul 28, 2017, 4:02 p.m.


HQL

/quotes/zigman/40749403/composite


$
21.65




Change

+0.06
+0.28%

Volume
Volume 58,490
Quotes are delayed by 20 min








/quotes/zigman/40749403/composite
Previous close

$
			21.59
		


$
				21.65
			
Change

+0.06
+0.28%





Day low
Day high
$21.50
$21.82










52 week low
52 week high

            $15.85
        

            $22.23
        

















Show All


8-K



10-K



10-Q



Proxy



Registration



13D



13F



13G







SEC Filings for Tekla Life Sciences Investors
    
Getting Started with SEC Filings



Filing Date
Document Date
Type
Category
Amended



04/18/2017


06/15/2017


DEF 14A


Proxy Statement







02/13/2017


N/A


SC 13G/A


Institutional Ownership


*




01/27/2017


N/A


SC 13G/A


Institutional Ownership


*




04/18/2016


06/14/2016


DEF 14A


Proxy Statement







04/04/2016


06/14/2016


PRE 14A


Proxy Statement







02/11/2016


N/A


SC 13G


Institutional Ownership







01/25/2016


N/A


SC 13G/A


Institutional Ownership


*




04/20/2015


06/04/2015


DEF 14A


Proxy Statement







01/23/2015


N/A


SC 13G/A


Institutional Ownership


*




04/30/2014


06/09/2014


DEF 14A


Proxy Statement







01/17/2014


N/A


SC 13G/A


Institutional Ownership


*




07/10/2013


N/A


SC 13G/A


Institutional Ownership


*




04/25/2013


06/04/2013


DEF 14A


Proxy Statement







03/25/2013


03/22/2013


8-K


Special Events







02/07/2013


N/A


SC 13G


Institutional Ownership







02/07/2013


N/A


SC 13G


Institutional Ownership







04/30/2012


06/11/2012


DEF 14A


Proxy Statement







03/23/2012


03/23/2012


8-K


Special Events







06/30/2011


06/30/2011


8-K


Special Events







06/08/2011


07/08/2011


DEF 14A


Proxy Statement









More...





      SEC Filings provided by EDGAR Online, Inc.















Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/65801738/composite TLT+1.11%


/quotes/zigman/59386294/composite JNUG-5.94%


X




Powered by














Log In




7:14 PM EDT
July 28, 2017


/marketstate/country/us
New York

	After


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
6:50pWall Street isn’t ready for a 1,100-point tumble in the Dow industrials
6:32pThe dark side of cruises
6:32pThe highest paid athletes in the world, in one chart
6:31pO.J. Simpson made over $400,000 while in prison and won’t have to give any of it to the Goldman family
6:31p Trump to Police: 'Don't Be Too Nice'
6:31pHere are 10 co-workers you should avoid like the plague — especially in meetings
6:29pTop 10 most annoying people you may want to unfriend on Facebook 
6:29pThis is one person you should never unfriend on Facebook...
6:29p3 horrible ways typos could alter the course of your life
6:27pPaint your bathroom this color and boost your home’s selling price by $5,400
6:27pAmericans’ new badge of honor: ‘I was blocked by a celebrity!’
6:27p5 weird things I found out about America in my first 24 hours 
6:14pBeyond Tesla: 7 stocks driving the autonomous car revolution
6:14pThese 7 highly taxed companies need Congress to finally act on tax reform
6:11pWatch out: ‘Kids’ are making the most money in this stock market 
6:10p7 real ways for millennials to save money (not by brownbagging and skipping Starbucks)
6:09p‘Game of Thrones’: This computer model predicts who will be killed off — or survive
6:09pThis basic balanced index fund is beating the hedge fund averages
6:08pHere’s one Trump fan who might make you some money
5:58pWhy it might be time to invest in the companies Amazon is destroying
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,830.31

+33.76
+0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,374.68

-7.51
-0.12%





s&p 500

/quotes/zigman/3870025/realtime
2,472.10

-3.32
-0.13%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15























































HQL Stock Price - Tekla Life Sciences Investors Stock Quote (U.S.: NYSE) - MarketWatch



























 














































 















Sections

Watchlist




























Signup
 • 
Login

Search







Bulletin











US
Europe
Asia
FX
Rates
Futures


Range


1D
5D
1M
3M
6M
1Y
2Y











Dow

21,830.31


33.76


0.15%











S&P 500

2,472.10


-3.32


-0.13%











Nasdaq

6,374.68


-7.51


-0.12%











GlobalDow

2,848.22


-2.86


-0.10%











Gold

1,275.60


9.10


0.72%











Oil

49.79


0.75


1.53%

















S&P 500 Movers(%)



ALGN 
10.0




MHK 
4.3




COL 
4.3




LYB 
3.9






FLS
-10.9




MO
-9.5




SBUX
-9.2




GT
-8.4














Latest NewsAll Times Eastern








6:50p

Updated
Wall Street isn’t ready for a 1,100-point tumble in the Dow industrials



6:32p

Updated
The dark side of cruises



6:31p

 Trump to Police: 'Don't Be Too Nice'



6:31p

Updated
The highest paid athletes in the world, in one chart



6:31p

Updated
O.J. Simpson made over $400,000 while in prison and won’t have to give any of it to the Goldman family



6:30p

Updated
Here are 10 co-workers you should avoid like the plague — especially in meetings



6:29p

Updated
Top 10 most annoying people you may want to unfriend on Facebook 



6:28p

Updated
This is one person you should never unfriend on Facebook...



6:28p

Updated
3 horrible ways typos could alter the course of your life



6:27p

Updated
Paint your bathroom this color and boost your home’s selling price by $5,400












to be replaced

























































































































    




Home


Investing


Quotes


Stocks


United States


HQL


Overview



Compare Quotes
Stock Screener
Earnings Calendar
Sectors
NYSE

 



HQL
U.S.: NYSE


Join TD Ameritrade

Find a Broker


Tekla Life Sciences Investors

Watchlist 
CreateHQLAlert



  


Closed

Last Updated: Jul 28, 2017 4:02 p.m. EDT
Delayed quote



$
21.65



0.06
0.28%






Previous Close




$21.5900





  









Advanced Charting


1D
5D
1M
3M
6M
YTD
1Y
3Y
All




$
%
Vol


Advanced Charting

  




84.32% vs Avg.




                Volume:               
                
                    58.5K
                


                65 Day Avg. - 69.4K
            





Open: 21.50
Close: 21.65



21.5000
Day Low/High
21.8200





Day Range



15.8500
52 Week Low/High
22.2300


   








Your Watchlist



Customize MarketWatch
Have Watchlists? Log in to see them here or sign up to get started.

Create Account

                    … or Log In

















Symbol
Last
Chg
Chg %

















No Items in Watchlist
There are currently no items in this Watchlist.

Add Ticker to Watchlist




 (Go to Your Watchlist) 




No Saved Watchlists
Create a list of the investments you want to track.

Create Watchlist

                    …or try this starter list






Uh oh
Something went wrong while loading Watchlist.

Go to Watchlist



 

Recently Viewed Tickers



No Recent Tickers
Visit a quote page and your recently viewed tickers will be displayed here.

Search Tickers



















   





Overview


Profile


News


Charts


Financials


Historical Quotes


Analyst Estimates


Options


SEC Filings


Insiders



   




Key Data



Open
$21.50



Day Range
21.5000 - 21.8200



52 Week Range
15.8500 - 22.2300



Market Cap
n/a



Shares Outstanding
21.17M



Public Float
n/a



Beta
1.23



Rev. per Employee
n/a



P/E Ratio
n/a



EPS
n/a



Yield
7.58%



Dividend
$0.41



Ex-Dividend Date
May 30, 2017



Short Interest
123.08K
07/14/17


% of Float Shorted
n/a



Average Volume
69.36K




 


Performance




5 Day


-0.92%







1 Month


3.84%







3 Month


5.61%







YTD


27.43%







1 Year


13.53%









  

 
 


Recent News



MarketWatch
Other Dow Jones










Is this the final stage of the bull market?


Apr. 18, 2011 at 4:21 p.m. ET
by Nate Pile, Nate's Notes









Top performer offers free advice


Mar. 4, 2010 at 12:49 a.m. ET
by Peter Brimelow









Dividend-oriented closed-end funds look attractive


Apr. 29, 2008 at 12:09 p.m. ET
by MarketWatch









Discounts, activist shareholders make for closed-end fund bargains


Apr. 29, 2008 at 7:23 a.m. ET
by Chuck Jaffe









Nate Pile's noteworthy 'rifle-shot' accuracy


Jan. 12, 2006 at 6:52 a.m. ET
by Peter Brimelow









'First-tier' biotech stocks hitting 52-week highs


Apr. 26, 2005 at 1:42 p.m. ET
by Nate Pile









Pharma stocks to continue higher


Dec. 29, 2003 at 10:44 a.m. ET
by Nate Pile









H&Q Life Sciences declares 29 cent stock dividend


Feb. 7, 2003 at 12:58 p.m. ET
by Jenny Spitz









Coke, Checkpoint Systems and more


May. 27, 2002 at 9:17 p.m. ET
by CBS.MarketWatch.com









Stocks to watch Tuesday


May. 25, 2002 at 4:51 p.m. ET
by CBS.MarketWatch.com













Income Generators


Jun. 3, 2013 at 3:19 p.m. ET
on Barron's









The New Doctor in the House: Consolidation


Feb. 3, 2011 at 5:01 a.m. ET
on SmartMoney











More Mergers Expected in the Drug Industry

Feb. 1, 2011 at 8:45 a.m. ET
on Barron's














Recent News



Other News
Press Releases






Takeover Deals Weaken At Opposite Ends Of The Market
Takeover Deals Weaken At Opposite Ends Of The Market

Jul. 20, 2017 at 1:08 p.m. ET
on Seeking Alpha





Not Over Til It's Over - U.S. Lawmakers Plan New Health Program Restraints
Not Over Til It's Over - U.S. Lawmakers Plan New Health Program Restraints

Jul. 19, 2017 at 2:22 p.m. ET
on Seeking Alpha





Delving For The Drivers Of Pharma's Disappearing Deals
Delving For The Drivers Of Pharma's Disappearing Deals

Jul. 18, 2017 at 3:28 p.m. ET
on Seeking Alpha





2017 On Course For Uptick In Device Approvals
2017 On Course For Uptick In Device Approvals

Jul. 17, 2017 at 3:53 p.m. ET
on Seeking Alpha





Medtech Venture Funding Total Hits All-Time High
Medtech Venture Funding Total Hits All-Time High

Jul. 12, 2017 at 2:43 p.m. ET
on Seeking Alpha





Venture Financing Still Positive But Big Rounds Less Common
Venture Financing Still Positive But Big Rounds Less Common

Jul. 12, 2017 at 10:48 a.m. ET
on Seeking Alpha





The Month In Closed-End Funds: June 2017
The Month In Closed-End Funds: June 2017

Jul. 10, 2017 at 3:58 p.m. ET
on Seeking Alpha





Closed End Funds And Capital Preservation
Closed End Funds And Capital Preservation

Jul. 8, 2017 at 4:25 a.m. ET
on Seeking Alpha





The Chemist's CEF Report - June 2017: Unusual Calm
The Chemist's CEF Report - June 2017: Unusual Calm

Jul. 5, 2017 at 10:14 a.m. ET
on Seeking Alpha





Health of the healthcare bill?
Health of the healthcare bill?

Jun. 26, 2017 at 4:46 a.m. ET
on Seeking Alpha





DC Gives Biopharma Investors A Rosy Second-Half Outlook
DC Gives Biopharma Investors A Rosy Second-Half Outlook

Jun. 22, 2017 at 2:44 p.m. ET
on Seeking Alpha





Biotechs blaze as Trump draft order on drug prices would ease regulations
Biotechs blaze as Trump draft order on drug prices would ease regulations

Jun. 21, 2017 at 7:22 p.m. ET
on Seeking Alpha





Total Worldwide Drug Sales Forecast To Fall As Uncertainty Hits Pharma
Total Worldwide Drug Sales Forecast To Fall As Uncertainty Hits Pharma

Jun. 20, 2017 at 3:00 p.m. ET
on Seeking Alpha





WSJ's Grant: In biotech, no news is bad news
WSJ's Grant: In biotech, no news is bad news

Jun. 7, 2017 at 2:02 p.m. ET
on Seeking Alpha





Early Liquid Biopsy Data Hint At Grail's Travails
Early Liquid Biopsy Data Hint At Grail's Travails

Jun. 6, 2017 at 9:27 a.m. ET
on Seeking Alpha





2 Bold Biotech Predictions For The 2nd Half Of 2017
2 Bold Biotech Predictions For The 2nd Half Of 2017

Jun. 6, 2017 at 9:39 a.m. ET
on Seeking Alpha





Gilead: A Strong Bet For Income
Gilead: A Strong Bet For Income

Jun. 4, 2017 at 3:53 p.m. ET
on Seeking Alpha





Trump Budget Plans Double FDA Review Costs
Trump Budget Plans Double FDA Review Costs

May. 24, 2017 at 9:01 a.m. ET
on Seeking Alpha





Nanobiotix Turns Up The Heat
Nanobiotix Turns Up The Heat

May. 19, 2017 at 12:00 p.m. ET
on Seeking Alpha





Obamacare Repeal Vote The First Move On Congressional Chess Board
Obamacare Repeal Vote The First Move On Congressional Chess Board

May. 5, 2017 at 3:46 p.m. ET
on Seeking Alpha









Tekla Life Sciences Investors Paid Distribution
Tekla Life Sciences Investors Paid Distribution

Jun. 30, 2017 at 2:42 p.m. ET
on BusinessWire - BZX





Tekla Healthcare Opportunities Fund Paid Distribution
Tekla Healthcare Opportunities Fund Paid Distribution

Jun. 30, 2017 at 2:42 p.m. ET
on BusinessWire - BZX





Tekla World Healthcare Fund Paid Distribution
Tekla World Healthcare Fund Paid Distribution

Jun. 30, 2017 at 2:42 p.m. ET
on BusinessWire - BZX





Tekla Healthcare Investors Paid Distribution
Tekla Healthcare Investors Paid Distribution

Jun. 30, 2017 at 2:42 p.m. ET
on BusinessWire - BZX





Tekla Funds Announce Results of Joint Annual Shareholders Meeting
Tekla Funds Announce Results of Joint Annual Shareholders Meeting

Jun. 15, 2017 at 4:16 p.m. ET
on BusinessWire - BZX





Tekla Life Sciences Investors Announces Results of Annual 
      Shareholders Meeting
Tekla Life Sciences Investors Announces Results of Annual 
      Shareholders Meeting

Jun. 15, 2017 at 4:16 p.m. ET
on BusinessWire - BZX





Tekla World Healthcare Fund Paid Distribution
Tekla World Healthcare Fund Paid Distribution

May. 31, 2017 at 11:16 a.m. ET
on BusinessWire - BZX





Tekla Healthcare Opportunities Fund Paid Distribution
Tekla Healthcare Opportunities Fund Paid Distribution

May. 31, 2017 at 11:16 a.m. ET
on BusinessWire - BZX





CORRECTING and REPLACING Tekla Life Sciences Investors Declares Stock 
      Distribution
CORRECTING and REPLACING Tekla Life Sciences Investors Declares Stock 
      Distribution

May. 22, 2017 at 12:43 p.m. ET
on BusinessWire - BZX





Tekla Life Sciences Investors Declares Stock Distribution
Tekla Life Sciences Investors Declares Stock Distribution

May. 19, 2017 at 11:36 a.m. ET
on BusinessWire - BZX





Tekla Healthcare Opportunities Fund Paid Distribution


Apr. 28, 2017 at 2:32 p.m. ET
on BusinessWire - BZX





Tekla World Healthcare Fund Paid Distribution


Apr. 28, 2017 at 2:32 p.m. ET
on BusinessWire - BZX





Tekla Healthcare Investors Paid Distribution


Mar. 31, 2017 at 1:03 p.m. ET
on BusinessWire - BZX





Tekla Healthcare Opportunities Fund Paid Distribution


Mar. 31, 2017 at 1:02 p.m. ET
on BusinessWire - BZX





Tekla Life Sciences Investors Paid Distribution


Mar. 31, 2017 at 1:02 p.m. ET
on BusinessWire - BZX





Tekla World Healthcare Fund Paid Distribution


Mar. 31, 2017 at 1:02 p.m. ET
on BusinessWire - BZX





Tekla Life Sciences Investors Announce Renewal of Share Repurchase 
      Program


Mar. 23, 2017 at 1:46 p.m. ET
on BusinessWire - BZX





Tekla World Healthcare Fund Paid Distribution


Feb. 28, 2017 at 3:07 p.m. ET
on BusinessWire - BZX





Tekla Healthcare Opportunities Fund Paid Distribution


Feb. 28, 2017 at 3:07 p.m. ET
on BusinessWire - BZX





Tekla Life Sciences Investors Declares Stock Distribution


Feb. 17, 2017 at 1:40 p.m. ET
on BusinessWire - BZX








  



 
   






   



























Partner Content























Trending Tickers
Powered by 





DVAX

0.00%








MO

-9.49%








SSTI

-0.08%








CLVS

6.25%








ICPT

4.22%
























Advanced Search







Stocks



Columns


Authors


Topics







No results found





























Video Center










Learn more.Storyful, a division of News Corp, which owns MarketWatch, is a leading social media services company headquartered in Dublin, Ireland. Storyful combines world class journalism with industry-leading technology to discover, verify and acquire original content and provide the on-the-ground sources news and media organizations need to tell the stories that matter to their audience.












HQL Stock Price - Tekla Life Sciences Investors Stock Quote (U.S.: NYSE) - MarketWatch



























 














































 















Sections

Watchlist




























Signup
 • 
Login

Search







Bulletin











US
Europe
Asia
FX
Rates
Futures


Range


1D
5D
1M
3M
6M
1Y
2Y











Dow

21,830.31


33.76


0.15%











S&P 500

2,472.10


-3.32


-0.13%











Nasdaq

6,374.68


-7.51


-0.12%











GlobalDow

2,848.22


-2.86


-0.10%











Gold

1,275.60


9.10


0.72%











Oil

49.79


0.75


1.53%

















S&P 500 Movers(%)



ALGN 
10.0




MHK 
4.3




COL 
4.3




LYB 
3.9






FLS
-10.9




MO
-9.5




SBUX
-9.2




GT
-8.4














Latest NewsAll Times Eastern








6:50p

Updated
Wall Street isn’t ready for a 1,100-point tumble in the Dow industrials



6:32p

Updated
The dark side of cruises



6:31p

 Trump to Police: 'Don't Be Too Nice'



6:31p

Updated
The highest paid athletes in the world, in one chart



6:31p

Updated
O.J. Simpson made over $400,000 while in prison and won’t have to give any of it to the Goldman family



6:30p

Updated
Here are 10 co-workers you should avoid like the plague — especially in meetings



6:29p

Updated
Top 10 most annoying people you may want to unfriend on Facebook 



6:28p

Updated
This is one person you should never unfriend on Facebook...



6:28p

Updated
3 horrible ways typos could alter the course of your life



6:27p

Updated
Paint your bathroom this color and boost your home’s selling price by $5,400












to be replaced

























































































































    




Home


Investing


Quotes


Stocks


United States


HQL


Overview



Compare Quotes
Stock Screener
Earnings Calendar
Sectors
NYSE

 



HQL
U.S.: NYSE


Join TD Ameritrade

Find a Broker


Tekla Life Sciences Investors

Watchlist 
CreateHQLAlert



  


Closed

Last Updated: Jul 28, 2017 4:02 p.m. EDT
Delayed quote



$
21.65



0.06
0.28%






Previous Close




$21.5900





  









Advanced Charting


1D
5D
1M
3M
6M
YTD
1Y
3Y
All




$
%
Vol


Advanced Charting

  




84.32% vs Avg.




                Volume:               
                
                    58.5K
                


                65 Day Avg. - 69.4K
            





Open: 21.50
Close: 21.65



21.5000
Day Low/High
21.8200





Day Range



15.8500
52 Week Low/High
22.2300


   








Your Watchlist



Customize MarketWatch
Have Watchlists? Log in to see them here or sign up to get started.

Create Account

                    … or Log In

















Symbol
Last
Chg
Chg %

















No Items in Watchlist
There are currently no items in this Watchlist.

Add Ticker to Watchlist




 (Go to Your Watchlist) 




No Saved Watchlists
Create a list of the investments you want to track.

Create Watchlist

                    …or try this starter list






Uh oh
Something went wrong while loading Watchlist.

Go to Watchlist



 

Recently Viewed Tickers



No Recent Tickers
Visit a quote page and your recently viewed tickers will be displayed here.

Search Tickers



















   





Overview


Profile


News


Charts


Financials


Historical Quotes


Analyst Estimates


Options


SEC Filings


Insiders



   




Key Data



Open
$21.50



Day Range
21.5000 - 21.8200



52 Week Range
15.8500 - 22.2300



Market Cap
n/a



Shares Outstanding
21.17M



Public Float
n/a



Beta
1.23



Rev. per Employee
n/a



P/E Ratio
n/a



EPS
n/a



Yield
7.58%



Dividend
$0.41



Ex-Dividend Date
May 30, 2017



Short Interest
123.08K
07/14/17


% of Float Shorted
n/a



Average Volume
69.36K




 


Performance




5 Day


-0.92%







1 Month


3.84%







3 Month


5.61%







YTD


27.43%







1 Year


13.53%









  

 
 


Recent News



MarketWatch
Other Dow Jones










Is this the final stage of the bull market?


Apr. 18, 2011 at 4:21 p.m. ET
by Nate Pile, Nate's Notes









Top performer offers free advice


Mar. 4, 2010 at 12:49 a.m. ET
by Peter Brimelow









Dividend-oriented closed-end funds look attractive


Apr. 29, 2008 at 12:09 p.m. ET
by MarketWatch









Discounts, activist shareholders make for closed-end fund bargains


Apr. 29, 2008 at 7:23 a.m. ET
by Chuck Jaffe









Nate Pile's noteworthy 'rifle-shot' accuracy


Jan. 12, 2006 at 6:52 a.m. ET
by Peter Brimelow









'First-tier' biotech stocks hitting 52-week highs


Apr. 26, 2005 at 1:42 p.m. ET
by Nate Pile









Pharma stocks to continue higher


Dec. 29, 2003 at 10:44 a.m. ET
by Nate Pile









H&Q Life Sciences declares 29 cent stock dividend


Feb. 7, 2003 at 12:58 p.m. ET
by Jenny Spitz









Coke, Checkpoint Systems and more


May. 27, 2002 at 9:17 p.m. ET
by CBS.MarketWatch.com









Stocks to watch Tuesday


May. 25, 2002 at 4:51 p.m. ET
by CBS.MarketWatch.com













Income Generators


Jun. 3, 2013 at 3:19 p.m. ET
on Barron's









The New Doctor in the House: Consolidation


Feb. 3, 2011 at 5:01 a.m. ET
on SmartMoney











More Mergers Expected in the Drug Industry

Feb. 1, 2011 at 8:45 a.m. ET
on Barron's














Recent News



Other News
Press Releases






Takeover Deals Weaken At Opposite Ends Of The Market
Takeover Deals Weaken At Opposite Ends Of The Market

Jul. 20, 2017 at 1:08 p.m. ET
on Seeking Alpha





Not Over Til It's Over - U.S. Lawmakers Plan New Health Program Restraints
Not Over Til It's Over - U.S. Lawmakers Plan New Health Program Restraints

Jul. 19, 2017 at 2:22 p.m. ET
on Seeking Alpha





Delving For The Drivers Of Pharma's Disappearing Deals
Delving For The Drivers Of Pharma's Disappearing Deals

Jul. 18, 2017 at 3:28 p.m. ET
on Seeking Alpha





2017 On Course For Uptick In Device Approvals
2017 On Course For Uptick In Device Approvals

Jul. 17, 2017 at 3:53 p.m. ET
on Seeking Alpha





Medtech Venture Funding Total Hits All-Time High
Medtech Venture Funding Total Hits All-Time High

Jul. 12, 2017 at 2:43 p.m. ET
on Seeking Alpha





Venture Financing Still Positive But Big Rounds Less Common
Venture Financing Still Positive But Big Rounds Less Common

Jul. 12, 2017 at 10:48 a.m. ET
on Seeking Alpha





The Month In Closed-End Funds: June 2017
The Month In Closed-End Funds: June 2017

Jul. 10, 2017 at 3:58 p.m. ET
on Seeking Alpha





Closed End Funds And Capital Preservation
Closed End Funds And Capital Preservation

Jul. 8, 2017 at 4:25 a.m. ET
on Seeking Alpha





The Chemist's CEF Report - June 2017: Unusual Calm
The Chemist's CEF Report - June 2017: Unusual Calm

Jul. 5, 2017 at 10:14 a.m. ET
on Seeking Alpha





Health of the healthcare bill?
Health of the healthcare bill?

Jun. 26, 2017 at 4:46 a.m. ET
on Seeking Alpha





DC Gives Biopharma Investors A Rosy Second-Half Outlook
DC Gives Biopharma Investors A Rosy Second-Half Outlook

Jun. 22, 2017 at 2:44 p.m. ET
on Seeking Alpha





Biotechs blaze as Trump draft order on drug prices would ease regulations
Biotechs blaze as Trump draft order on drug prices would ease regulations

Jun. 21, 2017 at 7:22 p.m. ET
on Seeking Alpha





Total Worldwide Drug Sales Forecast To Fall As Uncertainty Hits Pharma
Total Worldwide Drug Sales Forecast To Fall As Uncertainty Hits Pharma

Jun. 20, 2017 at 3:00 p.m. ET
on Seeking Alpha





WSJ's Grant: In biotech, no news is bad news
WSJ's Grant: In biotech, no news is bad news

Jun. 7, 2017 at 2:02 p.m. ET
on Seeking Alpha





Early Liquid Biopsy Data Hint At Grail's Travails
Early Liquid Biopsy Data Hint At Grail's Travails

Jun. 6, 2017 at 9:27 a.m. ET
on Seeking Alpha





2 Bold Biotech Predictions For The 2nd Half Of 2017
2 Bold Biotech Predictions For The 2nd Half Of 2017

Jun. 6, 2017 at 9:39 a.m. ET
on Seeking Alpha





Gilead: A Strong Bet For Income
Gilead: A Strong Bet For Income

Jun. 4, 2017 at 3:53 p.m. ET
on Seeking Alpha





Trump Budget Plans Double FDA Review Costs
Trump Budget Plans Double FDA Review Costs

May. 24, 2017 at 9:01 a.m. ET
on Seeking Alpha





Nanobiotix Turns Up The Heat
Nanobiotix Turns Up The Heat

May. 19, 2017 at 12:00 p.m. ET
on Seeking Alpha





Obamacare Repeal Vote The First Move On Congressional Chess Board
Obamacare Repeal Vote The First Move On Congressional Chess Board

May. 5, 2017 at 3:46 p.m. ET
on Seeking Alpha









Tekla Life Sciences Investors Paid Distribution
Tekla Life Sciences Investors Paid Distribution

Jun. 30, 2017 at 2:42 p.m. ET
on BusinessWire - BZX





Tekla Healthcare Opportunities Fund Paid Distribution
Tekla Healthcare Opportunities Fund Paid Distribution

Jun. 30, 2017 at 2:42 p.m. ET
on BusinessWire - BZX





Tekla World Healthcare Fund Paid Distribution
Tekla World Healthcare Fund Paid Distribution

Jun. 30, 2017 at 2:42 p.m. ET
on BusinessWire - BZX





Tekla Healthcare Investors Paid Distribution
Tekla Healthcare Investors Paid Distribution

Jun. 30, 2017 at 2:42 p.m. ET
on BusinessWire - BZX





Tekla Funds Announce Results of Joint Annual Shareholders Meeting
Tekla Funds Announce Results of Joint Annual Shareholders Meeting

Jun. 15, 2017 at 4:16 p.m. ET
on BusinessWire - BZX





Tekla Life Sciences Investors Announces Results of Annual 
      Shareholders Meeting
Tekla Life Sciences Investors Announces Results of Annual 
      Shareholders Meeting

Jun. 15, 2017 at 4:16 p.m. ET
on BusinessWire - BZX





Tekla World Healthcare Fund Paid Distribution
Tekla World Healthcare Fund Paid Distribution

May. 31, 2017 at 11:16 a.m. ET
on BusinessWire - BZX





Tekla Healthcare Opportunities Fund Paid Distribution
Tekla Healthcare Opportunities Fund Paid Distribution

May. 31, 2017 at 11:16 a.m. ET
on BusinessWire - BZX





CORRECTING and REPLACING Tekla Life Sciences Investors Declares Stock 
      Distribution
CORRECTING and REPLACING Tekla Life Sciences Investors Declares Stock 
      Distribution

May. 22, 2017 at 12:43 p.m. ET
on BusinessWire - BZX





Tekla Life Sciences Investors Declares Stock Distribution
Tekla Life Sciences Investors Declares Stock Distribution

May. 19, 2017 at 11:36 a.m. ET
on BusinessWire - BZX





Tekla Healthcare Opportunities Fund Paid Distribution


Apr. 28, 2017 at 2:32 p.m. ET
on BusinessWire - BZX





Tekla World Healthcare Fund Paid Distribution


Apr. 28, 2017 at 2:32 p.m. ET
on BusinessWire - BZX





Tekla Healthcare Investors Paid Distribution


Mar. 31, 2017 at 1:03 p.m. ET
on BusinessWire - BZX





Tekla Healthcare Opportunities Fund Paid Distribution


Mar. 31, 2017 at 1:02 p.m. ET
on BusinessWire - BZX





Tekla Life Sciences Investors Paid Distribution


Mar. 31, 2017 at 1:02 p.m. ET
on BusinessWire - BZX





Tekla World Healthcare Fund Paid Distribution


Mar. 31, 2017 at 1:02 p.m. ET
on BusinessWire - BZX





Tekla Life Sciences Investors Announce Renewal of Share Repurchase 
      Program


Mar. 23, 2017 at 1:46 p.m. ET
on BusinessWire - BZX





Tekla World Healthcare Fund Paid Distribution


Feb. 28, 2017 at 3:07 p.m. ET
on BusinessWire - BZX





Tekla Healthcare Opportunities Fund Paid Distribution


Feb. 28, 2017 at 3:07 p.m. ET
on BusinessWire - BZX





Tekla Life Sciences Investors Declares Stock Distribution


Feb. 17, 2017 at 1:40 p.m. ET
on BusinessWire - BZX








  



 
   






   



























Partner Content























Trending Tickers
Powered by 





DVAX

0.00%








MO

-9.49%








SSTI

-0.08%








CLVS

6.25%








ICPT

4.22%
























Advanced Search







Stocks



Columns


Authors


Topics







No results found





























Video Center










Learn more.Storyful, a division of News Corp, which owns MarketWatch, is a leading social media services company headquartered in Dublin, Ireland. Storyful combines world class journalism with industry-leading technology to discover, verify and acquire original content and provide the on-the-ground sources news and media organizations need to tell the stories that matter to their audience.


















 HQL: Quote and summary for Tekla Life Sciences Investors - MSN Money















msn  back to msn home

money










web search














Sign in








Change language & content:

América Latina (español)
Argentina (español)
Australia (English)
België (Nederlands)
Belgique (français)
Brasil (português)
Canada (English)
Canada (français)
Chile (español)
Colombia (español)
Danmark (Dansk)
Deutschland (Deutsch)
España (español)
France (français)
India (English)
Indonesia (Bahasa Indonesia)
Ireland (English)
Italia (italiano)
Malaysia (English)
México (español)
Nederland (Nederlands)
New Zealand (English)
Norge (norsk, bokmål)
Österreich (Deutsch)
Perú (español)
Philippines (English)
Polska (polski)
Portugal (Português)
Schweiz (Deutsch)
Singapore (English)
South Africa (English)
Suisse (français)
Suomi (suomi)
Sverige (svenska)
Türkiye (Türkçe)
United Arab Emirates (English)
United Kingdom (English)
United States (English)
United States (español)
Venezuela (español)
Việt Nam (Tiếng Việt)
Ελλάδα (ελληνικά)
Россия (Pусский)
ישראל (עברית)‏
الإمارات العربية المتحدة (العربية‏)
المملكة العربية السعودية (العربية‏)
مصر (العربية‏)
ไทย (ไทย)
한국 (한국어)
中华人民共和国 (简体中文)
台灣 (繁體中文)
日本 (日本語)
香港特别行政區 (繁體中文)



Switch to Latino (Español)



 Feedback



Help






























AdChoices














Tekla Life Sciences Investors
NYSE: HQL



US Markets Closed










AdChoices








21.65


▲


+0.06
+0.28%



 : 






 July 28, 2017 4:02 PM EDT. Delayed 15 minutes. Currency In USD                
















Save














 Summary




 Analysis



















































Open
21.50


Previous Close
21.59


Vol (3-Month Avg.)
69.12k


Day's Range
21.50-21.82


52 week range
15.85-22.23


Net Assets
459.94M


Yield
0.00%


Category
Health


Morningstar Risk
-







Profile






Name of Issuer


Hambrecht & Quist




Expenses


1.27%







To seek long-term capital appreciation by investing primarily in equity and equity related securities of US and non-US companies principally engaged in the development, production or distribution of products or services related to scientific advances in healthcare, agriculture and environmental management. Under normal market conditions, the Trust will invest at least 65% of its total assets in securities of Life Sciences Companies. The Trust may also invest up to 40% of its net assets in securities subject to legal or contractual restrictions as to resale and up to 25% in securities of foreign issuers, expected to be located primarily in Western Europe, Canada and Japan.





-





Inception
5/8/1992














Recent News







Daniel R. Omstead M.S, Ph.D.

                            
                            Bloomberg
                        
7/21/2017






Key Executives for Tekla Life Sciences Investors

                            
                            Bloomberg
                        
7/20/2017






Tekla Life Sciences Investors Paid Distribution

                            
                            news.morningstar.com
                        
6/30/2017






Tekla Life Sciences Investors Paid Distribution

                            
                            Morning Star
                        
6/30/2017






Tekla Life Sciences Investors Cash Flow - Annual (NYSE:HQL)

                            
                            amigobulls.com
                        
7/20/2017






Tekla Life Sciences Investors (HQL)

                            
                            investing.com
                        
7/18/2017








Tekla Life Sciences Investors

                            
                            markets.ft.com
                        
7/17/2017






Tekla Healthcare Investors (NYSE:HQH) Experiences Lighter than Usual Trading Volume

                            
                            fidaily.com
                        
7/17/2017






Tekla Life Sciences Investors Annual Income Statement (NYSE:HQL)

                            
                            amigobulls.com
                        
7/11/2017






Tekla Life Sciences Investors Paid Distribution

                            
                            Wallstreet online
                        
6/30/2017






Tekla Life Sciences Investors Paid Distribution

                            
                            TMCnet.com
                        
6/30/2017






Tekla Life Sciences Investors Paid Distribution

                            
                            Fox 19
                        
6/30/2017








Tekla Life Sciences Investors Paid Distribution

                            
                            ABC 9 KTRE
                        
6/30/2017






Tekla Life Sciences Investors Paid Distribution

                            
                            WWBT-TV NBC 12
                        
6/30/2017






Tekla Life Sciences Investors Paid Distribution

                            
                            Fox 8 WVUE-TV
                        
6/30/2017






Tekla World Healthcare Fund Paid Distribution

                            
                            Fox 19
                        
6/30/2017






Tekla World Healthcare Fund Paid Distribution

                            
                            Fox 8 WVUE-TV
                        
6/30/2017






Tekla Healthcare Opportunities Fund Paid Distribution

                            
                            ABC 9 KTRE
                        
6/30/2017
























AdChoices

















AdChoices




















Markets











DOW

DOW



▲

21,830.31


+33.76
+0.15%













Last updated time
7/28/2017 4:38 PM EDT







Markets





NASDAQ

NASDAQ



▼

6,374.68




-7.51
-0.12%










FTSE 100

FTSE 100



▼

7,368.37




-74.64
-1.00%










NYSE Composite

NYSE Composite



▼

11,954.69




-8.54
-0.07%



















AdChoices
















                Feedback
            







Send Feedback
Provide Feedback
Report a Problem


We appreciate your input!



Select a category:

I'm having problems with Top Destinations
I'm having issues searching
I'm having problems with Featured Apps
I see an error in the content
Other



How we can improve?





Please give an overall site rating:









Submit
Close


Privacy Statement


Help


Help & Support



 











 



Tekla Life Sciences Investors Announces Results of Annual Shareholders MeetingHomeMailFlickrTumblrNewsSportsFinanceCelebrityAnswersGroupsMobileMoreTry Yahoo Finance on Firefox »YahooSearchSearchSign inU.S. Markets closedS&P 5002,472.10-3.32 (-0.13%)Dow 3021,830.31+33.76 (+0.15%)Nasdaq6,374.68-7.51 (-0.12%)LISTENWho is the face of pro baseball?Yahoo Finance's Dan Roberts and Myles Udland debate the business of baseballTekla Life Sciences Investors Announces Results of Annual Shareholders MeetingBusiness WireJune 15, 2017ReblogShareTweetShareBOSTON--(BUSINESS WIRE)--The Board of Trustees of Tekla Life Sciences Investors (HQL), is pleased to announce the results from the Fund’s annual shareholder meeting held today.Shareholders re-elected Oleg Pohotsky and William Reardon as Trustees of Tekla Life Sciences Investors.The shareholders also ratified the selection of Deloitte & Touche LLP as the Independent Registered Public Accountants of the Fund for its fiscal year ending September 30, 2017.In addition, the shareholders rejected a shareholder proposal to reorganize the Board of Trustees into one class with each Trustee subject to election each year.Tekla Life Sciences Investors (HQL) is a closed-end fund that invests in companies in the life sciences and other healthcare industry.Tekla Capital Management LLC is a Boston, MA based healthcare-focused investment manager with approximately $3.1 billion of assets under management as of March 31, 2017. Tekla also serves as investment adviser to three other closed-end funds: Tekla Healthcare Investors (HQH), Tekla Healthcare Opportunities Fund (THQ) and Tekla World Healthcare Fund (THW). Information regarding the Fund and Tekla Capital Management LLC can be found at www.teklacap.com.Destra Capital Investments is the Fund’s marketing and investor support services agent. Please contact Destra Capital Investments at (877)855-3434 if you have any questions.View source version on businesswire.com: http://www.businesswire.com/news/home/20170615006252/en/ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextBehind Uber’s Messy CEO Search Is a Divided BoardroomBloombergThis Will Be In Everyone's Household By 2020Banyan HillSponsoredTrump to cops: 'Please don't be too nice' while arresting 'thugs,' and don't worry about their heads when you toss them in the 'paddy wagon'Business InsiderHere are the US targets North Korea most likely wants to nukeBusiness InsiderThe 'two pizza rule' is a secret to productive meetings that helped Amazon CEO Jeff Bezos become one of the world's richest menBusiness InsiderEngineer Finds Pattern; Makes Millions in StocksMoney MorningSponsoredChevron and Exxon Mobil have a tough path ahead: NYSE traderYahoo Finance VideoStocks mixed after heavy earnings weekTrump names John F. Kelly new chief of staff; Reince Priebus outCNBCHuman Barbie Takes Off Make Up, Drs Are SpeechlessKiwi ReportSponsoredThe real reason overseas manufacturing is coming to AmericaYahoo FinanceNorth Korea 2nd ICBM test puts much of US in range: expertsAssociated PressMy bullish view on stocks hasn't changed one iota: NYSE traderYahoo Finance VideoWhat's the Problem with Joel Osteen?ChurchLeaders.comSponsoredBlue Apron: Bullish calls not all they're cooked up to beYahoo FinanceA major player in the struggle for control of the Sinaloa cartel just surrendered in the USBusiness InsiderTrump Is Acting Suspicious Because He ‘May Be’ Innocent, Fox News SaysBen: I always hire a slew of lawyers when I haven't done anything so it makes perfect sense. 😂😂Join the Conversation1 / 51.6k








Tekla Life Sciences Investors Paid DistributionHomeMailFlickrTumblrNewsSportsFinanceCelebrityAnswersGroupsMobileMoreTry Yahoo Finance on Firefox »YahooSearchSearchSign inU.S. Markets closedS&P 5002,472.10-3.32 (-0.13%)Dow 3021,830.31+33.76 (+0.15%)Nasdaq6,374.68-7.51 (-0.12%)LISTENWho is the face of pro baseball?Yahoo Finance's Dan Roberts and Myles Udland debate the business of baseballTekla Life Sciences Investors Paid DistributionBusiness WireJune 30, 2017ReblogShareTweetShareBOSTON--(BUSINESS WIRE)--On June 30, 2017, Tekla Life Sciences Investors paid a distribution of $0.41 per share. It is currently estimated that this distribution is derived from long-term capital gains. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $169,921,052, of which $134,750,869 represents net unrealized appreciation of portfolio securities.The following table sets forth the estimated amounts of the current distribution, paid on June 30, 2017, and the cumulative distributions paid this fiscal year-to-date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains, return of capital or other capital source. All amounts are expressed per common share.                                                           Current Distribution             Percentage Breakdown of Current Distribution             Total Cumulative Distributions for the Fiscal Year to Date1             Percentage Breakdown of the Total Cumulative Distributions for the Fiscal Year to Date1      Net Investment Income           $0.0000           0%           $0.0000           0%     Net Realized ST Cap Gains           $0.0000           0%           $0.0000           0%     Net Realized LT Cap Gains           $0.4100           100%           $1.1700           100%     Return of Capital or Other Capital Source           $0.0000           0%           $0.0000           0%     TOTAL (per common share):           $0.4100           100%           $1.1700           100%                                The table below includes information relating to the Fund’s performance based on its NAV for certain periods.                Average annual return at NAV for the period from May 31, 2012 through May 31, 2017           16.06%     Annualized current distribution rate expressed as percentage of NAV as of May 31, 2017           8.41%     Cumulative total return at NAV for the fiscal year, through May 31, 20172           3.85%     Cumulative fiscal year-to-date distribution rate expressed as a percentage of NAV as of May 31, 20171           6.00%              You should not draw any conclusions about the Fund’s investment performance from the amount of this distribution or from the terms of the Fund’s managed distribution policy.The amounts and sources of distributions reported in this press release are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund’s investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.Tekla Life Sciences Investors (HQL) is a closed-end fund that invests in companies in the healthcare industry.Tekla Capital Management LLC, the Fund’s investment adviser, is a Boston, MA based healthcare-focused investment manager with approximately $3.1 billion of net assets under management as of March 31, 2017. Tekla also serves as investment adviser to Tekla Healthcare Investors (HQH), Tekla Healthcare Opportunities Fund (THQ) and Tekla World Healthcare Fund (THW), closed-end funds that invest in companies in the healthcare and life sciences industries. Information regarding the Funds and Tekla Capital Management LLC can be found at www.teklacap.com.Destra Capital Investments is the Fund’s marketing and investor support services agent. Please contact Destra Capital Investments at HQL@destracapital.com or call (877) 855-3434 if you have any questions regarding HQL.1 The Fund’s current fiscal year began on October 1, 2016.2 Cumulative total return at NAV is the percentage change in the Fund’s NAV and includes all distributions and assumes the reinvestment of those distributions for the period of September 30, 2016 through May 31, 2017.View source version on businesswire.com: http://www.businesswire.com/news/home/20170630005645/en/ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextTrump to cops: 'Please don't be too nice' while arresting 'thugs,' and don't worry about their heads when you toss them in the 'paddy wagon'Business InsiderThis Will Be In Everyone's Household By 2020Banyan HillSponsoredHere are the US targets North Korea most likely wants to nukeBusiness InsiderThe 'two pizza rule' is a secret to productive meetings that helped Amazon CEO Jeff Bezos become one of the world's richest menBusiness InsiderChevron and Exxon Mobil have a tough path ahead: NYSE traderYahoo Finance VideoEngineer Finds Pattern; Makes Millions in StocksMoney MorningSponsoredStocks mixed after heavy earnings weekTrump names John F. Kelly new chief of staff; Reince Priebus outCNBCThe real reason overseas manufacturing is coming to AmericaYahoo FinanceHuman Barbie Takes Off Make Up, Drs Are SpeechlessKiwi ReportSponsoredNorth Korea 2nd ICBM test puts much of US in range: expertsAssociated PressMy bullish view on stocks hasn't changed one iota: NYSE traderYahoo Finance VideoBlue Apron: Bullish calls not all they're cooked up to beYahoo FinanceWhat's the Problem with Joel Osteen?ChurchLeaders.comSponsoredA major player in the struggle for control of the Sinaloa cartel just surrendered in the USBusiness InsiderTax cuts just got more likelyYahoo FinanceTrump Is Acting Suspicious Because He ‘May Be’ Innocent, Fox News SaysBen: I always hire a slew of lawyers when I haven't done anything so it makes perfect sense. 😂😂Join the Conversation1 / 51.6k








